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ABSTRACT OF THE DISSERTATION
Chlorinated Tyrosine Species as Markers of Inflammation: A Kinetic Study
by
Matthew Peter Curtis
Doctor of Philosophy, Graduate Program in Biochemistry
Loma Linda University, June 2015
Dr. Jonathan W. Neidigh, Chairperson

Chronic inflammation is associated with numerous human diseases. During
inflammation, leukocytes release the enzyme myeloperoxidase (MPO) which generates
reactive oxygen species such as hypochlorous acid (HOCl). Additionally, MPO generates
reactive nitrogen species. These reactive species can damage host fats, proteins, and
DNA, contributing to disease pathology.
Because of the reactivity and short half-lives of reactive species, measurement of
surrogate markers is necessary to determine their extent and source. Chlorination of the
tyrosine phenol ring by HOCl to produce 3-chlorotyrosine (3ClTyr) or nitration of the
phenol ring by reactive nitrogen species to produce 3-nitrotyrosine (NO2Tyr) are two
such markers. Both are stable byproducts of MPO activity and are readily measurable.
Some studies, however, have called into question their use as biomarkers of
inflammation. Concentrations of 3ClTyr or NO2Tyr reportedly decrease upon exposure to
HOCl, suggesting that any measurement of these in vivo would be underestimated. These
studies, however, failed to quantify the rate of degradation and did not identify the
products.
Furthermore, there is some evidence to suggest that, in vivo, chlorination of
tyrosine by HOCl occurs through chloramine intermediates rather than directly. This is
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evidenced by the preferential chlorination of tyrosine residues that are nearby lysine or
histidine, whose side-chain amines react with HOCl to become chloramines. This
contradicts the relatively slow reactions kinetics of tyrosine chlorination by histidine or
lysine chloramine and warrants further investigation.
In these studies, we identify the product of 3ClTyr and NO2Tyr reacting with
HOCl as 3,5-dichlorotyrosine (Cl2Tyr) and 3-chloro-5-nitrotyrosine (ClNO2Tyr),
respectively. The second-order rate constants of the chlorination of tyrosine, 3ClTyr, and
NO2Tyr by HOCl, histidine chloramine, and lysine chloramine are reported. The
relevance of Cl2Tyr and ClNO2Tyr in vivo are discussed.
Additionally, we investigate the kinetics of tyrosine chlorination in the context of
a lysine- or histidine-containing peptide. The rate of chlorination of tyrosine within a
peptide is dependent on the primary and secondary structure and is a first-order,
intramolecular reaction. These studies further support the role of chloramines in the
chlorination of protein-bound tyrosine and, to our knowledge, are the first to provide rate
constants.
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CHAPTER ONE
INTRODUCTION
Inflammation Contributes to Disease Pathology
Inflammation is a defensive response triggered by damage to living tissues. Its
purpose is to localize and eliminate any harmful agents and remove damaged components
so that the body can begin the healing process. However, prolonged periods of
inflammation can be more harmful than beneficial. Chronic inflammation can eventually
lead to tissue destruction and the functional impairments that characterize many human
disease conditions.1 The generation of reactive oxygen species (ROS) in inflammatory
tissue is thought to drive proinflammatory cytokine production, thus prolonging the
duration of the inflammatory process and contributing to the pathogenesis of human
diseases.2
The human diseases that are associated with chronic inflammation and reactive
oxygen species are varied, affecting numerous organ systems with different presentations.
Chronic inflammation has been implicated in the pathology of disorders including
psoriasis of the skin,3 arthritis of the joints,4 lung diseases,5-7 cardiovascular disease,8-10
and neurodegenerative diseases.11-13 Even cancers are associated with chronic
inflammation, as seen in the increased incidence of colorectal cancer in patients with
inflammatory bowel disease,14, 15 increased production of reactive species in breast
tumors,16, 17 and studies linking inflammation with tumorigenesis.18-21 As reactive species
have been implicated in more and more disease pathologies, there has been a greater
effort to study their generation and to measure their effects in tissue.
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Myeloperoxidase Creates Chlorinating and Nitrating Species
Neutrophils are a major source of reactive oxygen species and are likely
contributors to the diseases in which inflammatory cells participate.22 Neutrophils that
have been activated by cytokines during inflammation generate superoxide and its
dismutase byproduct, hydrogen peroxide. In addition, the heme enzyme myeloperoxidase
(MPO) is released which has the unique ability to catalyze the reaction between chloride
ions and hydrogen peroxide to create hypochlorous acid (HOCl).23
HOCl is a highly reactive species that can react to form either oxidized or
chlorinated products. In vivo, there are many potential targets of HOCl including nucleic
acids, lipids, and proteins.24, 25 Reactions with proteins are especially common due to
their relative abundance. HOCl reacts rapidly with thiols or thioesters on cysteine or
methionine side-chains,26 with free amines on the N-terminus or lysine and histidine sidechains to give chloramines,27 and with the phenol ring of tyrosine producing 3chlorotyrosine (3ClTyr).28 These reactions damage proteins thus impairing their normal
function.29 For example, apolipoprotein A-I, which normally removes cholesterol from
macrophages, can by oxidized by HOCl, impairing its ability to remove cholesterol and
contributing to atherosclerosis of arteries.30
In addition to oxidation and chlorination, MPO participates in the generation of
reactive nitrating agents. Two such species are nitrogen dioxide (NO2•), which is
generated by the oxidation of nitrite (NO2-) by MPO,31 and nitryl chloride (NO2Cl2),
which is generated by the oxidation of NO2- by MPO-derived HOCl.32, 33 These reactive
nitrogen species can result in modulation of the catalytic activity of enzymes through
nitration. For example, nitration of cyclooxygenase-2 results in inhibition, shortening the
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inflammatory response,34 or nitration can inhibit mitochondrial respiration, leading to cell
death.35-37 Nitration of tyrosine by NO2Cl or NO2• results in the formation of 3nitrotyrosine (NO2Tyr). Figure 1 provides a summary of reactions involving MPO that
results in the generation of reactive nitrogen species and ROS.

Tyrosine Analogues as Markers of MPO Activity
Biomarkers of reactant species have the potential to allow researchers and
clinicians the ability to determine the extent of oxidative injury and identify the source of
the oxidative stress. Unfortunately, finding an appropriate biomarker can be challenging.
Expression of MPO, for example, has been correlated to disease pathology,38-40 but its use
as a potential biomarker of reactive species is complicated by the presence of both active
and inactive forms of the enzyme.41-43 Direct measurement of oxidative species
themselves is also difficult because of their high reactivity and short lifetime in biological
environments.44 Instead, surrogate markers, often the product of a reactive species with a
biological molecule, need to be measured to study the role of reactive species in disease
pathology.45, 46
The characteristics of a good biomarker include specificity, stability, and
measurability.24 Specificity means that the marker is only produced by the reactive
species or enzyme in question. For example, MPO is the only human enzyme to produce
HOCl and is present predominantly in neutrophils and monocytes.47 Thus, HOCl or
HOCl-derived byproducts would be specific markers of the oxidant activity of
neutrophils and other MPO-containing cells.

3

Figure 1: Potential Pathways of Tyrosine Chlorination and Nitration by MPO. Cl‒,
chloride; H2O2, hydrogen peroxide; HOCl, hypochlorous acid; iNOS, inducible nitric oxide
synthase; MPO, myeloperoxidase; NO•, nitric oxide; NO2•, nitrogen dioxide; NO2‒, nitrite;
NO2Cl, nitryl chloride; O2•, superoxide; ONOO‒, peroxynitrite.
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Stability implies that a molecule is able to persist for great lengths of time in
physiologic conditions, without degrading further, reacting with other molecules, or
being enzymatically repaired. DNA bases, for instance, are oxidized or chlorinated by
HOCl to form hydroxyuracil, 5-hydroxycytosine, 8-chloroadenosine, 5-chlorocytosine,
and more.48-50 However, the repair of damaged DNA molecules, with the possible
exception of 5-chlorocytosine,51 precludes their use as biomarkers of HOCl.
Chloramines, the byproduct of HOCl with free protein amines, also continue to react with
other molecules at high rates and have relatively short half-lives.52, 53 Chlorination or
nitration of tyrosine by MPO-derived compounds to make 3ClTyr or NO2Tyr, however,
produce more stable end products that persist for long periods of time in vivo.54, 55
Measurability of a potential biomarker means that there are laboratory techniques
or instruments to measure the marker that are consistent and sensitive. In the case of
3ClTyr and NO2Tyr, several methods of measuring these compounds exist. 3ClTyr can
be measured qualitatively by antibody-based immunoassays56, 57 or quantitatively
measured by mass spectrometry58 and HPLC.59 NO2Tyr can likewise be measured using
HPLC60 and tandem mass spectrometry,61, 62 while its measurement by immunoassays is
still undergoing investigation.63 Because they are unique byproducts of MPO activity,
stable, and quantifiable, both 3ClTyr and NO2Tyr are promising potential biomarkers of
the extent of MPO activity in inflamed tissue.

The Purpose of These Studies
While much of the literature appears to support the role of 3ClTyr and NO2Tyr as
biomarkers of MPO in inflamed tissue, two studies in particular have called into question
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their stability and usefulness as biomarkers. One study qualitatively describes the loss of
measureable 3ClTyr upon exposure to HOCl.59 Likewise, the second study shows
concentrations of NO2Tyr decrease when exposed to HOCl.64 These studies suggest a
more complicated relationship with HOCl and implicate that these markers have been
underestimated in previous reports. Neither of these studies, however, quantitatively
measured the rate of disappearance nor suggested what the products of such a reaction
would be.
In addition, it has been suggested by other studies that, in vivo, tyrosine is more
likely to be chlorinated by HOCl-derived chloramines than by HOCl directly.44, 47 Even
though the rate of tyrosine chlorination by lysine chloramine as free amino acids appears
too slow to be of significance,65 several different groups have shown preferential
chlorination of tyrosine residues within proteins that are near in space to histidine or
lysine residues.55, 65, 66 Though this pattern has been established, there have been no
studies into the exact mechanism of tyrosine chlorination in this context nor the
quantification of the rates of chlorination.
Our purpose in these studies is to investigate the disappearance of 3ClTyr and
NO2Tyr on exposure to HOCl, to determine what role chloramines play in tyrosine
chlorination, and to investigate how tyrosine chlorination differs in the context of a
peptide. Our first study identifies the product of 3ClTyr reacting with HOCl, measures
the rate at which 3ClTyr disappears, and shows how lysine and histidine chloramines are
able to accomplish tyrosine chlorination as well, albeit slower than HOCl (Chapter 2).
The second study focuses on the disappearance of NO2Tyr when it reacts with HOCl,
again investigating the role of chloramines, but this study further investigates the
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mechanism of how chloramines are able to more favorably chlorinate tyrosine when they
are located on the same peptide (Chapter 3). Our last study looks at how changes in the
primary or secondary structure of a peptide that place tyrosine and chloramine residues
closer in space are able to change the reaction kinetics, significantly speeding up the rate
of chlorination when compared to free amino acids (Chapter 4). Finally, our conclusions
are summarized and the relevance of our findings in regards to the role of 3ClTyr and
NO2Tyr as biomarkers of MPO activity are discussed in the context of our current
understanding of the literature (Chapter 5).
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Abstract
The persistent activation of innate immune cells in chronic inflammation is
gaining recognition as a contributing factor in a number of human diseases. A
distinguishing feature of activated leukocytes at sites of inflammation is their production
of reactive species such as hypochlorous acid (HOCl). Investigating the role of reactive
molecules like HOCl in inflammation and human disease requires appropriate
biomarkers. The preferred biomarker for HOCl, and by extension its synthesizing enzyme
myeloperoxidase, is 3-chlorotyrosine. 3-Chlorotyrosine is a chemically stable product
formed when HOCl, or a HOCl-induced chloramine, reacts with the tyrosine side-chain
and is readily measured by sensitive mass spectrometry methods. However, Whiteman
and Spencer1 recently noted that 3-chlorotyrosine is degraded by HOCl, calling into
question its use as a biomarker. The kinetic rate constants of HOCl, histidine chloramine,
and lysine chloramine reacting with 3-chlorotyrosine to form 3,5-dichlorotyrosine are
reported. The kinetics of tyrosine chlorination in the context of a peptide with a nearby
lysine residue was also determined and further supports the role of chloramines in the
chlorination of protein-bound tyrosine residues. The likelihood of free 3,5dichlorotyrosine occurring in vivo, given the reported rate constants, is discussed.
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Introduction
The persistent activation of innate immune cells in chronic inflammation is
gaining recognition as a contributing factor in numerous human diseases including
diabetes, neurodegeneration, atherosclerosis, and cancer.2-7 The reactive species
superoxide, hydrogen peroxide, hypochlorous acid (HOCl), and hypobromous acid are
generated by human leukocytes.8 Myeloperoxidase (MPO), found in neutrophils,
monocytes, and macrophages, generates HOCl using hydrogen peroxide to oxidize
chloride ions.9 While HOCl kills invading microorganisms, it is also toxic to host cells.10,
11

These reactive species, produced at sites of inflammation, are thought to contribute to

the pathology of human disease.12
However, the direct measurement of HOCl is not feasible because of its reactivity
and short half-life in biological environments.13 While expression of MPO correlates with
pathologies including cardiovascular disease,14, 15 cancer,7, 16 and neurodegenerative
disease,17-19 measurement of MPO as a biomarker for reactive species is complicated by
the presence of both active and inactive forms of the enzyme.20-22 The products that result
when reactive species damage biological molecules are instead used as surrogate markers
to investigate the role of reactive species in disease pathology.23,24
Surrogate markers of HOCl result from the reaction of HOCl with nucleic acids,
proteins, and lipids.25 HOCl oxidizes DNA bases forming 5-hydroxyuracil, 5hydoxycytosine, and thymine glycol.26 HOCl can also chlorinate DNA forming 8chloroguanosine, 8-chloroadenosine, and 5-chlorocytosine.27 HOCl-generated DNA
damage will result in mutations if not repaired.28, 29 However, the repair of damaged
DNA, with the possible exception of 5-chlorocytosine,30 likely precludes the use of these
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HOCl damage products as a biomarker of HOCl. Furthermore, DNA and lipid oxidation
or chlorination are slower than the reactions of HOCl with protein side-chains suggesting
that protein damage will reach higher concentrations in vivo.31-34
Products of both oxidation and chlorination damage occur when proteins or amino
acids are exposed to HOCl.35 The preferred marker of HOCl in vivo is 3-chlorotyrosine
(3ClTyr); a stable and unique product qualitatively measured by antibody-based
methods36, 37 or quantitatively measured by mass spectrometry.38 As most tyrosine is
incorporated into cellular proteins, in vivo measurements of 3ClTyr focus on proteinbound tyrosine and 3ClTyr. Measurements of 3ClTyr in human tissues were found to
correlate with other measurements of disease.39-41 Given the clinical connection between
inflammation and human diseases, researchers will continue to use 3ClTyr as a biomarker
to determine the role of HOCl in the etiology of these diseases.
The reported kinetics of tyrosine chlorination by HOCl is slow relative to the rate
of reaction with other protein side-chains.31 The observation of 3ClTyr in vivo indicates
that HOCl was formed in sufficient quantities to chlorinate tyrosine despite the slow rate
measured in vitro. However, Whiteman and Spencer report that 3ClTyr is lost when
exposed to HOCl suggesting a more complicated relationship between HOCl and 3ClTyr,
calling into question the use of 3ClTyr as a biomarker.1 Previous articles suggested that
3ClTyr reacts with HOCl to form 3,5-dichlorotyrosine (Cl2Tyr).42-46 However, the
kinetics of HOCl reacting with 3ClTyr is not known nor did the above cited papers
attempt to measure Cl2Tyr in vivo. In this study we report the kinetics of 3ClTyr
chlorination to form Cl2Tyr.
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Our early experiments also noted a discrepancy with the previously reported
model used to calculate the kinetics of tyrosine chlorination; the appearance of UV/Vis
absorbance bands at 240 and 300 nm was observed and attributed to an intermediate
product preceding formation of 3ClTyr.31 However, we have observed that authentic
samples of Cl2Tyr, not 3ClTyr or some unknown intermediate, contain UV/Vis
absorption peaks near 240 and 300 nm indicating the formation of Cl2Tyr during the
experiments reported to measure the chlorination of tyrosine to form 3ClTyr.
Furthermore, the buffer used in this previous study lacked chloride ions raising the
concern that their reported rate constants may not reflect the physiological rate if chloride
ions participate in the chlorination reaction. In this study we used an HPLC method and
authentic standards to remove ambiguity when determining the kinetics of tyrosine and
3ClTyr chlorination by HOCl and determined the impact of chloride ions on the kinetics
as a function of pH.
One solution to the slow rate of direct chlorination of tyrosine by HOCl is the
suggestion that the rapid chlorination of a lysine residue or N-terminal amino group to
form a chloramine will in turn rapidly chlorinate a nearby tyrosine residue.44, 47 However,
Pattison and Davies found that the chloramine of a lysine side-chain analogue very
slowly chlorinated tyrosine over nine days with low levels of chlorine incorporation.48 In
this study, we examine the kinetics whereby lysine chloramines chlorinate tyrosine
residues, both as individual amino acids and in the context of a polypeptide using mass
spectrometry to characterize the peptide products following reaction with HOCl.
At this time, an accurate estimate of the physiological quantities and
concentrations of HOCl reached in vivo is missing. The relative kinetics of reactions
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between HOCl and biological molecules is important for defining the normal and
pathological ranges of HOCl production in human tissues. The rate constants of 3ClTyr
chlorination, we argue, will allow more accurate estimates of HOCl formation in vivo.

Experimental Procedures
Materials
L-Tyrosine, N-acetyl-L-tyrosine (AcTyr), N-α-acetyl-L-lysine (AcLys), and Nacetyl-L-histidine (AcHis) were purchased from Novabiochem (San Diego, CA).
Fluorenylmethyloxycabonylchloride (FMOC)-amide resin was purchased from Applied
Biosystems, Inc. (Foster City, CA). FMOC-Lys(BOC)-OH, and all other FMOC-amino
acids were purchased from Advanced ChemTech (Louisville, KY). α-Cyano-4hydroxycinnamic acid matrix and peptide calibration standards were purchased from
Bruker (Billerica, MA). Sodium hypochlorite, 3-chloro-L-tyrosine, L-methionine, Nacetylglycine, N-acetyl-L-alanine, N-acetyl-L-glutamic acid, N-α-acetyl-L-asparagine,
and all other laboratory chemicals were purchased from Sigma-Aldrich (St. Louis, MO).

Synthesis of N-acetyl-3-chlorotyrosine
3-Chloro-L-tyrosine (1 g, 4.6 mmol) was acetylated with excess acetic anhydride
(4 ml, 42 mmol) in 100 ml acetone at room temperature (Figure 1). The crude product
containing N,O-diacetyl-3-chlorotyrosine was formed after reacting overnight and is
soluble in acetone. The acetone was removed using rotary evaporation after filtering off
any remaining insoluble impurities. Remaining acetic anhydride was hydrolyzed by
addition of water. The phenol acetate ester was rapidly hydrolyzed for one hour by
addition of 1M NaOH until the solution pH was between 8 and 9 resulting in the
19

A. Synthesis of Ac3ClTyr

B. Synthesis of AcCl2Tyr

Figure 1: Synthesis of Ac3ClTyr and AcCl2Tyr. Ac3ClTyr was synthesized by
acetylation of 3ClTyr with excess acetic anhydride (Ac2O) (A). AcCl2Tyr was synthesized
by chlorination of tyrosine with excess sulfuryl chloride (SO2Cl2) with subsequent
acetylation with excess Ac2O (B).
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formation of N-acetyl-3-chlorotyrosine (Ac3ClTyr) in high purity (> 95% pure). The
aqueous solution was acidified to a pH < 2 with concentrated hydrochloric acid and then
added to a SupelClean, LC-18 packing, solid phase extraction (SPE) column (Supelco,
Bellefonte, PA). Following washing with aqueous 0.1% trifluoroacetic acid (TFA), the
desired compound was eluted with 5-10% methanol, 0.1% TFA solution. Fractions of ≥
98% purity, as determined by analytical HPLC, were dried by vacuum centrifugation and
stored for later use. The compound gave the expected UV/Vis absorbance maximum at
279 nm.49 1H-NMR (500 MHz, DMSO-d6), δ: 9.79 (s, 1H, –OH), 8.17 (d, J = 8.1 Hz, 1H,
NH), 7.16 (d, J = 1.8 Hz, H2), 6.98 (dd, J = 1.8, 8.3 Hz, 1H, H6), 6.86 (d, J = 8.3 Hz, 1H,
H5), 4.33 (m, 1H, J = 5.0, 8.3, 9.5 Hz, H), 2.92 (dd, 1H, J = 5.0, 13.9 Hz, H), 2.72 (dd,
J = 9.5, 13.9 Hz, H), 1.79 (s, 3H, CH3).

Synthesis of N-acetyl-3,5-dichlorotyrosine
The procedure of Allevi et al. was used to synthesize 3,5-dichlorotyrosine
(Cl2Tyr) from tyrosine, which was then used without further purification.50 Cl2Tyr was
acetylated as described above for the acetylation of 3ClTyr (Figure 1). The desired
compound eluted from the C18 SPE column with a solution consisting of 20% methanol
and 0.1% TFA. The UV/Vis spectrum in 0.1 M HCl showed the expected absorbance
maximums at 281 and 287 nm.49 1H-NMR (500 MHz, DMSO-d6), δ: 9.94 (s, 1H, –OH),
8.15 (d, J = 8.2 Hz, 1H, NH), 7.21 (s, 2H, H2,6), 4.36 (m, J = 5.0, 8.2, 9.5 Hz, 1H, H),
2.94 (dd, J = 5.0, 13.8 Hz, 1H, H), 2.73 (dd, J = 9.5, 13.8 Hz, H), 1.78 (s, 3H, CH3).

21

Synthesis of Ac-KGNYAE-NH2
A small peptide, Ac-KGNYAE-NH2, was synthesized using solid phase synthesis
and fast FMOC chemistry on an Applied Biosystems (Foster City, CA) 433A peptide
synthesizer. The sequence of this peptide is identical to residues 36 to 41 of human
histone H2A. We used an FMOC-amide resin and FMOC-protected amino acids with the
lysine side-chain protected by a tert-butyloxycarbonyl (BOC) protecting group. After
synthesis, the N-terminal FMOC-group was removed with piperidine and acetylated by
acetic anhydride and triethylamine in dimethylformamide. The peptide was cleaved from
the resin and purified by HPLC as previously described.43 Following purification, the
peptide was characterized by MALDI-TOF in positive-ion mode and determined that the
peptide monoisotopic mass (M+H+) was 722.34 m/z; the expected monoisotopic mass is
722.35 m/z. The purity of the peptide was determined to be > 97% by analytical HPLC.

Methods
Sodium hypochlorite was stored at 4 °C. The pKa of HOCl is 7.5 resulting in
equal concentrations of hypochlorous acid and its conjugate base, hypochlorite, at
physiological pH. The term “hypochlorous acid” is thus used in this article to refer to
both the acid and its conjugate base. The concentration of the HOCl stock was
determined daily using the absorbance at 292 nm (292 nm = 350 M-1cm-1) for a fresh
dilution of the stock into 0.1 M NaOH.51 Dilutions of the HOCl stock were then made
into buffer. All reactions were initiated by the addition of HOCl and quenched by adding
10-fold excess methionine, which reacts rapidly with HOCl (~108 M-1s-1).31
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Tyrosine analogues with acetylated amine groups were used to avoid reaction
with HOCl forming a chloramine with subsequent degradation to aldehyde products.45
AcTyr, Ac3ClTyr, and N-acetyl-3,5-dichlorotyrosine (AcCl2Tyr) in 0.1 M HCl displayed
UV/Vis absorbance’s maximums at 274, 279, 287 nm with molar absorptivity values of
ε274 nm = 1368 M-1 cm-1, ε279 nm = 1879 M-1 cm-1 and ε287 nm = 1424 M-1 cm-1,
respectively.49

UV/Vis Spectroscopy of Tyrosine Chlorination by HOCl
The UV-spectra of AcTyr reacting with HOCl was measured on a Varian (Palo
Alto, CA) Cary 100 Bio UV-Visible Spectrophotometer in a 1-cm micro quartz cell. 350
µM Ac3ClTyr and 70 – 350 µM AcTyr were reacted with 200 µM HOCl at room
temperature and the spectra between 230 and 350 nm was measured every 22 seconds.

Reactions of Tyrosine Analogues with HOCl or Chloramines
Like previously published kinetics reports, all reactions were buffered with 100
mM phosphate buffer.31, 48 Most reactions added 200 M HOCl to concentrations
between 300 and 1500 M of AcTyr, Ac3ClTyr, and AcCl2Tyr. Reactions with Nacetylhistidine chloramine (AcHisCl) and N--acetyllysine chloramine (AcLysCl) were
done by premixing tyrosine analogues with excess AcHis or AcLys and then adding 200
µM HOCl for a final concentration of 1000 µM AcHis or AcLys. Reactions with N-acetyllysine dichloramine (AcLysCl2) were done by premixing AcLys with tyrosine
analogues and then adding 200 µM HOCl for a final concentration of 105 µM AcLys.
Reaction times between 1 and 120 seconds were mixed using a KinTek RQF-3 Rapid
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Quench Flow apparatus (Austin, TX) maintained at 37 °C while manual mixing was used
for reaction times longer than 15 seconds in an aluminum block maintained at 37 °C. The
sample, reaction, and exit loops of the KinTek Quench Flow system were calibrated
using a solution of AcTyr with known concentration according to the manufacturer’s
directions. The collected calibration samples were dried by vacuum centrifugation and
then a known volume of water was added to each sample and analyzed by UV/Vis to
calculate the loop volumes.

HPLC Measurement of Chlorination Products
The concentration of products and reactants in kinetics samples were measured
using a ThermoFinnigan (Waltham, MA) Surveyor HPLC system containing a MS Pump,
Autosampler, and PDA detector. Standard curves were generated using pure stocks (≥
98% pure) of AcTyr, Ac3ClTyr, and AcCl2Tyr (r2 ≥ 0.999). Separation of each analyte
was accomplished by using a Restek Ultra IBD column (C18, 3µm, 150 x 2.1 mm). The
initial solvent mix was 95% mobile phase A (0.1% aqueous TFA) and 5% mobile phase
B (0.85% TFA in acetonitrile) for 5 minutes followed by a linear gradient to 50% B over
20 minutes at a flow rate of 200 µL/min. The limit of detection (S/N ≥ 3) was ≈ 0.5 µM
while the limit of quantitation was 100 - 200 M depending on the analyte. Kinetics
samples were diluted as necessary to achieve a final concentration of analyte less than the
limit of quantitation. The Qual browser module of Xcalibur, ver. 1.3 (Thermo-Finnigan,
Ontario, Canada) was used to analyze the HPLC chromatogram. Standard curves were
obtained periodically to ensure that measured concentrations were accurate.
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Analysis of Kinetics Data and Determination of Rate Constants
Microsoft Excel was used to analyze all kinetics data using a model comparison
method.52 A time interval of 0.1 seconds was used to numerically model the differential
equations. The chemical models for chlorination of phenol analogues by HOCl are
presented in the Results section. The sum of the squared differences (SSD) was
calculated between the experimental and modeled concentrations for time points in a
kinetics experiment. The Solver tool in Excel was used to determine the optimized
second order rate constants that minimized the SSD giving SSDopt. The error in each rate
constant was estimated by determining the two rate constants that gave SSD =
SSDopt*(F(P/(N-P))+1) where F is the critical value of the F distribution, P is the number
of model parameters, and N is the number of data points.52 We chose a value of F
corresponding to the 95% confidence level. When multiple rate constants were used to
model the kinetics, the error in each rate constant was estimated while all other rate
constants were held at their optimized value. The rate constant values are reported as the
middle value ± ½*range; the middle value was calculated from the high and low SSD
values calculated above that defined the range of certainty (95% confidence level) and
were within 1% of the optimized value in most cases.

Dependence of Kinetics on Presence of Chloride and Solution pH
The reaction pH was varied from pH 4.0 to pH 10.5 and the kinetics of
chlorination were determined when 200 µM HOCl reacted with 690 µM AcTyr or 680
µM Ac3ClTyr at 37 °C. HOCl was prepared in phosphate buffer with or without chloride
(Cl-) so that the final concentration of Cl- during reaction was 140 mM. The reactions
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were stopped with a 10-fold excess of methionine after 1, 5, 10, 15, and 30 seconds using
the KinTek Quench flow system. The apparent rate constant was modeled as described in
the previous paragraph. The pH dependence of chlorination for tyrosine analogues was fit
to the equation kapparent = kw[phenol][HOCl] + kx([phenol][OCl-] + [phenolate][HOCl]) +
ky[phenolate][OCl-] + kz[H+][HOCl][Cl-] where the concentrations of the acid and
conjugate base of the tyrosine analogue or HOCl were determined by their pKa values.
The terms [phenol][OCl-] and [phenolate][HOCl] were combined because the optimized
rate constant for each term, when separated, was dependent on the value of the other
term. The concentration of chlorine (Cl2) formed at equilibrium is small relative to
HOCl/OCl- at the examined pH values indicating that any effect of chloride ion on the
chlorination kinetics was due to either the rate limiting reaction of Cl2 formation or the
rate of Cl2 reacting with tyrosine analogues.53 As the effect of chloride on chlorination
kinetics was observed to be a function of the rate of Cl2 formation, we included the effect
of chloride using the previously determined rate law.53

Chlorination of Tyrosine by HOCl in a Lysine-Containing Peptide
The concentration of the peptide, Ac-KGNYAE-NH2, was determined using
UV/Vis spectrometry and the molar absorptivity of tyrosine at 274 nm (ε274 nm = 1368 M1

cm-1). Reactions contained 125 µM peptide and 65 – 400 µM of HOCl and were

quenched with at least 10-fold excess methionine. Likewise, a mixture of the N-α-acetyl
analogues of lysine, glycine, asparagine, tyrosine, alanine, and glutamic acid, where each
amino acid was present at a concentration of 125 µM, was reacted with 65 – 400 µM
HOCl. Reactants were combined manually for reaction times between 15 seconds and 60
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minutes in an aluminum block maintained at 37 °C. The reactant and products were
quantitated by UV-detected HPLC. The peptide reaction products were identified by
isolating HPLC chromatographic peaks and by using MALDI-TOF mass spectrometry as
described in Appendix A.
Quantitation of Ac-KGNYAE-NH2 and its chloro- and dichlorotyrosine analogues
were based on the standard curve of the AcTyr analogues. While the retention times were
different, quantitation by this method closely matched initial quantitation by UV/Vis and
the sum of the peptide analogues remained constant throughout the reaction. Our
experience with Tyr and AcTyr indicated that differences in retention time, and thus
acetonitrile content of the solvent during elution from the column, did not result in
significant (p  0.05) changes in the calibration slope. Furthermore, our HPLC
quantitation method was compared with a previously established GC-MS method to
quantitating Tyr, 3ClTyr, and Cl2Tyr and showed no significant difference in
concentration (Appendix B). The apparent rate constant of tyrosine chlorination in the
peptide Ac-KGNYAE-NH2 or the equivalent mixture of N-acetyl amino acids was
determined as described above.

Results
HOCl Reacts with 3ClTyr to form Cl2Tyr
The reported loss of 3ClTyr in the presence of HOCl suggested caution when
using 3ClTyr as a biomarker for active MPO and HOCl in vivo.1 While the previous
reports showed that HOCl reacts with 3ClTyr to form Cl2Tyr,42, 44-46, 48 the kinetics of this
reaction and thus the likelihood that formation of Cl2Tyr is physiologically relevant are
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unknown. The changes in the UV spectrum when Ac3ClTyr is reacted with HOCl are
shown in Figure 2a. The product formed when HOCl reacts with Ac3ClTyr has
absorbance peaks at 247 and 305 nm, consistent with the UV spectrum of synthetic
AcCl2Tyr. However, the kinetics of tyrosine chlorination by HOCl reported by Pattison
and Davies attributed these absorbance peak to an intermediate compound following the
reaction of HOCl with the phenol ring of tyrosine and preceding the formation of 3ClTyr.
We therefore reexamined the kinetics of Tyr chlorination by HOCl to determine if
AcCl2Tyr was formed during the published experiments.31 Figures 2b and 2c show the
changes in the UV spectrum when AcTyr reacts with HOCl, matching the previously
described reaction conditions and results. The kinetics of UV spectra changes indicates
that HOCl reacts faster with Ac3ClTyr than with AcTyr. As Cl2Tyr was apparently
formed during the published kinetics experiments, the reported rate constant of tyrosine
chlorination may be in error.
The UV spectrum of authentic AcTyr, Ac3ClTyr, and AcCl2Tyr is shown in
Figure 3 at acidic, basic, and neutral pH values. The pH-dependence of the UV spectra
for AcTyr, Ac3ClTyr, and AcCl2Tyr was used to determine the phenol pKa values of 9.8,
8.5, and 6.7, respectively (Appendix C). The final purity of all compounds was ≥ 98% as
determined by analytical HPLC at the maximum absorbance circa 280 nm. These spectra
indicate the formation of both Ac3ClTyr and AcCl2Tyr when AcTyr reacts with HOCl
(Figure 2). As the UV spectra of these compounds overlap at pH 7.4, we instead used an
HPLC method to quantitate the formation of reaction products. The HPLC chromatogram
shown in Figure 4 confirms that both Ac3ClTyr and AcCl2Tyr are formed after 30
seconds when HOCl reacts with AcTyr under the same conditions as those reported while
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Figure 2: UV Spectroscopy of AcTyr or Ac3ClTyr Reacting with HOCl. HOCl reacts
with Ac3ClTyr more rapidly than with AcTyr. The initial spectrum is shown as a bold line
while the arrows show the changes in the spectra collected every subsequent 22 seconds.
All reactions were performed at room temperature (approximately 22 ºC) with 200 M
HOCl and (A) 350 M Ac3ClTyr, (B) 70 M AcTyr, or (C) 350 M AcTyr. The product
of the reaction of Ac3ClTyr with HOCl has peaks at 246 and 305 nm (panel A). These
peaks are also seen when HOCl reacts with small amounts of AcTyr (panel B) or with
excess AcTyr (panel C).
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Figure 3: UV Spectrum of Tyrosine Analogues at Varying pH Values. Phosphate buffer
at 100 mM was used to buffer the compounds in acidic, basic, and physiologic pH values.
The spectrum of (A) AcTyr and (B) Ac3ClTyr at physiological pH is similar to the
spectrum at acidic pH while the spectrum of (C) AcCl2Tyr is most similar to the spectrum
at basic pH.
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Figure 4: HPLC Detection of Products Formed when AcTyr Reacts with HOCl. Both
Ac3ClTyr and AcCl2Tyr are formed after 30 seconds when 350 µM AcTyr is reacted with
200 µM HOCl at 37 °C, pH 7.4. The peaks at 11.9, 16.1, and 18.6 minutes display identical
UV spectra and coelute with authentic standards of AcTyr, Ac3ClTyr, and AcCl2Tyr,
respectively.
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determining the published rate constants.31 The standards were important to verify the
identity of products and generate the standard curves for quantitation as described in the
Experimental Procedures section.

HOCl Chlorinates 3ClTyr More Rapidly than Tyr
The time course of tyrosine analogue chlorination was monitored using UVdetected HPLC. In all cases excess AcTyr, Ac3ClTyr, or AcCl2Tyr at nominal
concentrations of 350, 500, and 1000 M were exposed to chlorinating agent in 100 mM
phosphate buffer, pH 7.4. The chlorinating agent HOCl was rapidly consumed by
addition of excess methionine to stop the reaction at the desired reaction time, usually
between 1 second and 60 minutes. The chlorinating agents examined included HOCl, the
monochloramine of N-acetylhistidine (AcHisCl), and the mono- and dichloramines of Nacetyllysine. Figure 5a shows a representative kinetic experiment for the chlorination of
AcTyr by HOCl where first Ac3ClTyr and then AcCl2Tyr are formed.
The time-dependence of product formation was modeled using the differential
equations shown in Figure 6 to determine the rate constants. The reaction progress was
modeled numerically as described in the Experimental Procedures section. The rate
constants were determined by minimizing differences between the model and
experimental reaction progress curves. For reactions with excess AcTyr or Ac3ClTyr, the
loss of phenol reactant was equal to the formation of chlorinated products. However, the
loss of AcCl2Tyr following reaction with HOCl was less than the added chlorinating
agent, presumably due to the reaction of the unknown product with chlorinating agent.
Therefore, only the first 2 minutes, 15 minutes, or 48 hours were modeled for HOCl,
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Figure 5: Kinetics of AcTyr Chlorination by HOCl and AcHisCl. (A) 350 M AcTyr
or (B) 400 M AcTyr with 1000 M AcHis were reacted with 200 M HOCl at 37 ºC for
the indicated time; the reaction was stopped with excess methionine and the products were
quantitated by UV- detected HPLC. The solid lines in each panel represent the modeled
reaction progress with optimized rate constants. The rate constants k1, k2, and k3 for AcTyr,
Ac3ClTyr, and AcCl2Tyr, respectively, reacting with HOCl in panel A are 71, 238, and 32
M-1s-1. The rate constants k1, k2, and k3 for AcTyr, Ac3ClTyr, and AcCl2Tyr, respectively,
reacting with AcHisCl in panel B are 2.3, 7.0, and 1.7 M-1s-1.
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Figure 6: Kinetic Scheme for Modeling the Chlorination of AcTyr. (A) AcTyr is
converted to Ac3ClTyr that can also react with HOCl or chloramine to form AcCl 2Tyr.
AcCl2Tyr is consumed when exposed to HOCl or chloramine to form unknown products.
(B) The differential equations describing the change in AcTyr, Ac3ClTyr, and AcCl2Tyr
concentration used to numerically model the experimental data.

34

AcHisCl, or the lysine chloramines, respectively, to determine the rate constants for
AcCl2Tyr chlorination. For each chlorinating agent, all kinetics experiments at a given
temperature with at least three different concentrations of AcTyr, Ac3ClTyr, and
AcCl2Tyr were simultaneously modeled when determining the rate constants. The rate
constants are summarized in Table 1.

Chloride Increases Tyr Chlorination at Acidic pH Values
The effect of chloride ions on the kinetics of tyrosine analogue chlorination was
next investigated to determine the effect of chloride on the in vivo chlorination of proteinbound tyrosine. Approximate chloride concentrations in vivo range from 20 mM inside
cells, 116 mM in interstitial fluid, 100 mM in plasma, and up to 160 mM in the stomach.
In the presence of chloride, HOCl is in equilibrium with Cl2 as shown in equation 1.53

HOCl + Cl- + H+

Cl2 + H2O

Eq. 1

The pH-dependent nature of this equilibrium prompted an investigation of the pH
dependence of AcTyr and Ac3ClTyr chlorination by HOCl with and without chloride as
shown in Figure 7. The effect of chloride is only significant at acidic pH values as the
formation of Cl2 becomes favorable. In the absence of chloride, the apparent rate constant
was decomposed to species specific terms for the reaction of the phenol or phenolate ion
with HOCl or hypochlorite. Initial efforts indicated that the reaction of phenol with
hypochlorite was not distinguishable from the reaction of phenolate with HOCl
prompting combination of these two terms with a single rate constant. The modeled
species-specific rate constants indicate that chlorination of tyrosine occurs when the -OCl
reacts with the phenol or HOCl reacts with the phenolate as expected for an electrophilic
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Table 1. Rate Constants for Chlorination of Tyr Analogues by HOCl and
Chloramines. This table shows the rate constants calculated for AcTyr, Ac3ClTyr, and
AcCl2Tyr reacting with HOCl, AcHisCl, AcLysCl, and AcLysCl2. Rate constants are
second order (M-1s-1) and were determined at pH 7.4 in 100 mM phosphate buffer.
Analogue

Temp
(ºC)

HOCl

AcHisCl

AcLysCl

AcLysCl2

Reference

AcTyr

22

47 ± 14

9±2

-

-

31, 48

22

23 ± 2

2.0 ± 0.1

0.002 ± 0.001

0.002 ± 0.002

This Study

37

71 ± 8

3.0 ± 0.3

0.004 ± 0.003

0.003 ± 0.002

This Study

22

82 ± 7

6.6 ± 0.4

0.003 ± 0.001

0.009 ± 0.005

This Study

37

238 ± 27

10.4 ± 1.0

0.008 ± 0.002

0.012 ± 0.007

This Study

22

26 ± 3

1.2 ± 0.1

0.002 ± 0.002

0.004 ± 0.004

This Study

37

32 ± 6

1.7 ± 0.2

0.003 ± 0.002

0.006 ± 0.006

This Study

Ac3ClTyr

AcCl2Tyr
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Figure 7: Effect of Chloride and pH on Rate of Tyrosine Chlorination. Chloride causes
an increase in the apparent rate constant for the chlorination of tyrosine analogues by HOCl
at a low pH. (A) AcTyr and (B) Ac3ClTyr were reacted with HOCl with (red curve) and
without (blue curve) the presence of 140 mM chloride and modeled as described in the
Experimental Procedures section. The solid curves represent the optimized model while
the dashed lines represent the 95% confidence limits; overlap of these limits for the
presence and absence of chloride is shaded grey. The presence of chloride only causes a
significant increase in the apparent rate constant at acidic pH values. The AcTyr rate
constants without chloride, kw, kx, and ky, are 5.3, 142, 1.3M-1s-1, respectively. With
chloride, the AcTyr rate constants, kw, kx, ky, and kz, are, 25, 141, 0 M-1s-1, and 14026 M2 -1
s , respectively. The Ac3ClTyr rate constants without chloride, kw, kx, ky, are 4.8, 353, 27
M-1s-1. With chloride present, the Ac3ClTyr rate constants, kw, kx, ky, and kz, become 72,
363, 15 M-1s-1, and 3930 M-2s-1, respectively.

37

aromatic substitution reaction. As the equilibrium concentration of Cl2 prior to reaction
initiation is small relative to the quantity of chlorination product observed, the influence of
chloride was modeled by adding a term for the rate of Cl2 formation. The modeled value
of this chloride-dependent rate constant is similar to the reported rate constant of Cl2
formation indicating that Cl2 formation, not phenol chlorination by Cl2, is the rate-limiting
step in tyrosine chlorination at acidic pH values.53

Chloramines Chlorinate 3ClTyr More Rapidly than Tyr
Recent reports indicate that chlorination of protein-bound tyrosine is preferred
when a His or Lys residue is nearby, suggesting that the formation of 3ClTyr in vivo is
accelerated by first forming a histidine or lysine chloramine.43, 44, 47 The
monochloramines of AcHis and AcLys as well as the dichloramine of AcLys were
reacted with the tyrosine analogues AcTyr, Ac3ClTyr, and AcCl2Tyr. At the
concentrations used in this study, HOCl will rapidly react to form AcHisCl, AcLysCl, or
AcLysCl2 within one second. Figure 5b shows the chlorination of AcTyr by AcHisCl
where first Ac3ClTyr and then AcCl2Tyr are formed. All chlorinating agents also caused
AcCl2Tyr to disappear forming one or more unknown products. As this article focuses on
the use of 3ClTyr as a biomarker, the identity of these unknown products were not
pursued. The relative rate of chlorination in all cases by chlorinating agents was HOCl >
AcHisCl >> AcLysCl ≈ AcLysCl2. The kinetics of these reactions were determined as
described in the Experimental Procedures section above and were analogous to the
chlorination of tyrosine analogues by HOCl.
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Analysis of AcLysCl2 kinetics is complicated due to the interaction between the
three species of lysine. When AcLysCl2 chlorinates a tyrosine analogue, it becomes
AcLysCl that in turn can chlorinate a tyrosine analogue. Additionally, when AcLysCl
chlorinates AcTyr, it becomes AcLys, which can be rapidly chlorinated by AcLysCl2 to
become AcLysCl again.54 The complete data set of AcLysCl and AcLysCl2 reactions
were thus simultaneously modeled to determine separate rate constants for the mono- and
dichloramine of lysine. The complete progress curve for AcTyr or Ac3ClTyr was
modeled; only the first 15 minutes, 48 hours, or 48 hours of the progress curves of
AcCl2Tyr reacting with AcHisCl, AcLysCl, or AcLysCl2, respectively, were modeled due
to the apparent reaction of HOCl or chloramine with the unknown products. The rate
constants for AcHisCl are approximately 10- to 30-fold slower than those for HOCl and
the lysine chloramine rates are more than 10,000-fold slower (Table 1).

Lysine Chloramine Rapidly Chlorinates Tyrosine in the Context of a Peptide
The slow chlorination of AcTyr by lysine chloramines conflicts with the selective,
and more rapid, chlorination of tyrosine residues near a lysine residue in a peptide or
protein.43, 44 The effect of a nearby lysine residue on the kinetics of tyrosine chlorination
was examined in the context of the peptide Ac-KGNYAE-NH2. A mixture of N--acetyl
analogues corresponding to the amino acid content of this peptide was also reacted with
HOCl to serve as a control. Figure 8a shows the HPLC of 125 µM Ac-KGNYAE-NH2
after it has reacted with 0, 130, or 260 µM HOCl for 60 minutes at 37 °C. Each peak was
collected and analyzed by MALDI-TOF in positive- and negative-ion mode. The three
largest HPLC peaks had mass spectra peaks of 722.3, 756.2, and 790.2 m/z that
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Figure 8: Rapid Chlorination of Tyrosine by Lysine Chloramine in a Peptide.
Tyrosine in a peptide is more rapidly chlorinated by a nearby lysine chloramine than by
free AcLysCl. (A) HPLC of 125 µM Ac-KGNYAE-NH2 after a 60 minute reaction with
either 0, 130, or 260 µM HOCl. The peaks at 8.3, 12.6, and 14.0 minutes correspond to AcKGNXAE-NH2 with tyrosine, 3-chlorotyrosine, or 3,5-dichlorotyrosine, respectively, at
residue four. The peaks at 13.6, 15.6, and 16.8 minutes correspond to the lysine nitrile form
of the peptide with tyrosine, 3-chlorotyrosine, or 3,5-dichlorotyrosine, respectively. (B)
125 µM Ac-KGNYAE-NH2 was reacted with 130 µM HOCl, stopped with excess
methionine at the indicated time and then quantitated by UV-detected HPLC. The apparent
rate constant k1 was found to be 2.4 M-1s-1. (C) 125 µM Ac-KGNYAE-NH2 or 130 µM of
an equivalent N-acetyl amino acid mixture was reacted with 130 µM HOCl. Chlorination
incorporation was measured as Clincorporation = [3ClTyr] + 2 x [Cl2Tyr]. The chlorination of
tyrosine by a free lysine chloramine is much slower than by a lysine chloramine within the
same peptide.
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correspond to the M+H fragment of the peptide containing Tyr, 3ClTyr, and Cl2Tyr,
respectively. In negative ion mode, the MALDI showed three other peaks at 716.3, 750.3,
and 784.3 m/z that correspond to the loss of four hydrogen atoms on each of these three
analogues when the amine of lysine is oxidized to form a nitrile (Appendix B). HPLC
was used to monitor the reaction of the peptide and HOCl over an hour (Figure 8b) and a
rate constant k1 of 2.4 M-1s-1 was determined by modeling as described above.
Comparison of the chlorination kinetics for the tyrosine-containing peptide and amino
acid mixture highlights the acceleration of tyrosine chlorination by a nearby chloramine
(Figure 8c).

Discussion
The biomarker 3ClTyr is formed when HOCl chlorinates tyrosine. Active MPO,
secreted by leukocytes in the innate immune response or chronic inflammation,
synthesizes HOCl from a chloride ion and hydrogen peroxide. However, the reported loss
of 3ClTyr to form an unknown product in the presence of HOCl calls into question the
use of 3ClTyr as a biomarker of HOCl or active MPO.1 Previous studies indicate that
Cl2Tyr is formed when tyrosine-containing proteins are exposed to HOCl suggesting that
HOCl chlorinates 3ClTyr to form Cl2Tyr. This report is the first to determine the kinetics
of HOCl reacting with the side-chains of 3ClTyr and Cl2Tyr.42, 43, 45
Given the overlapping UV spectra of these compounds, an HPLC-UV approach
was chosen to monitoring the reaction kinetics. The examined compounds and
chlorination products were cleanly separated and easily quantitated. The standard curve
for all compounds examined gave excellent correlation coefficients, r2 ≥ 0.999; the
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standard error for measuring the concentrations of tyrosine analogues given these
standard curves was 8 – 12%.
The kinetic rate constants reported in Table 1 are 2- to 4-fold slower than those
previously reported.31, 48 We argue that this discrepancy is not due to the difference
between the UV spectroscopy and UV-HPLC methods. The changes to the UV spectrum
as HOCl reacts with AcTyr (Figure 2) are consistent with previous published
descriptions. However, the UV specta (Figure 3) of authentic AcTyr, Ac3ClTyr, and
AcCl2Tyr suggests, and the HPLC data confirms (Figure 4), that both Ac3ClTyr and
AcCl2Tyr are formed under the reported reaction conditions.31 The HPLC data (Figure 5)
clearly shows that Ac3ClTyr formation precedes appearance of AcCl2Tyr. However,
Pattison and Davies assigned the UV spectral peaks at 240 and 300 nm to an intermediate
compound between AcTyr and AcCl2Tyr while the results reported here indicate that
these spectral peaks are best assigned to AcCl2Tyr. The chemical model (Figure 6) used
to derive the rate constants (Table 1) reported here differs from that of Pattison and
Davies.31 We have no reason to question the other rate constants reported by Pattison and
Davies as the current criticism is limited to their proposed reaction scheme for AcTyr.31,
48

Nonetheless, the 2- to 4-fold slower rate constants of tyrosine chlorination are reported

here, despite their minor physiological importance relative to the competing reactions of
HOCl in vivo.
Despite the relatively slow reaction between HOCl and protein-bound tyrosine,
the observation of greater quantities of 3-chlorotyrosine in diseased tissues than normal
tissues indicates that HOCl production in vivo is sufficient to chlorinate tyrosine residues
in cellular proteins. Measurements in vivo observe 0 – 1000 mol 3ClTyr per mole
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tyrosine in various tissues and diseases.39, 55-61 The chlorination of specific proteins, such
as apolipoprotein A2 from atherosclerotic plaques reaches levels of 7000 mol 3ClTyr
per mol tyrosine.41
Consideration of the known rate constants from in vitro experiments offers some
insights into the meaning of in vivo 3ClTyr measurements. At the physiological
3ClTyr/Tyr ratio reported in the literature, the rate constants reported here predict only
1% of 3ClTyr would be chlorinated to form Cl2Tyr assuming no other biologically
relevant reactions are present. The competing reactions of HOCl with the sulfur
containing amino acids cysteine and methionine in proteins and glutathione are rapid with
rate constants faster than 1 x 108 M-1s-1.31, 62 Therefore, the presence of 3ClTyr observed
in vivo is usually interpreted to represent the lower limit of HOCl formation after the
available anti-oxidant glutathione is consumed.31, 62 The direct chlorination of 3ClTyr to
form Cl2Tyr in vivo, given the rate constants reported here, is unlikely at 3ClTyr/Tyr
ratios observed in vivo.
The reaction of HOCl with amines to form a chloramine, however, has emerged
from in vitro studies as the most likely pathway to form protein-bound 3ClTyr.43, 44
Tyrosine residues in peptides and proteins near the N-terminal amine group or on lysine
and histidine residues are preferentially chlorinated indicating that the formation of an
intermediate chloramine accelerates tyrosine chlorination.43, 44, 47 Because the in vivo
HOCl concentrations and quantities are not known, the physiological relevance of HOCl
used during in vitro experiments is uncertain, particularly as these in vitro reactions also
exclude glutathione. However, the quantity of Cl2Tyr formed is informative when 3ClTyr
formation, as a ratio to Tyr, is similar to that observed in vivo. Instead of Cl2Tyr values
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less than 1% as predicted above, in vitro experiments with histone proteins or BSA found
approximately 10% Cl2Tyr when 3ClTyr values were less than 7,000 mol/mol of
tyrosine, the current upper limit of 3ClTyr reported from in vivo samples.41-43
Furthermore, for histone H3 and BSA the quantity of HOCl needed to produce these
physiological quantities of 3ClTyr was less than the number of cysteine and/or
methionine residues indicating that either the kinetics of HOCl reduction by these
residues is less than expected, presumably due to burial by the protein structure, or that
acceleration of tyrosine chlorination by first forming nearby chloramines is sufficiently
fast to successfully compete with cysteine and methionine residues.
Chlorination of a peptide-bound tyrosine by a nearby lysine chloramine may be
further favored because of this chloramines decreased reactivity with glutathione (Figure
9). Lysine chloramine reacts more slowly with glutathione (~300 M-1s-1) than HOCl or
histidine chloramine, allowing lysine chloramine to persist longer in solution and
facilitate chlorination of nearby tyrosine residues.31, 62 Additionally, while lysine
chloramine can eventually undergo hydrolysis into an aldehyde or nitrile,65 chlorination
of a nearby tyrosine appears to be a more favorable reaction based on the absence of
lysine modifications and prevalence of 3ClTyr in previous studies.42, 43
The primary limitation of the chloramine rate constants reported in Table 1 is that
they are bimolecular and represent the restriction of more degrees of freedom during
chlorination of tyrosine than would occur when a chloramine chlorinates a nearby
tyrosine residue on the same polypeptide chain. Inclusion of a nearby lysine residue on
the same peptide chain accelerated the rate of tyrosine chlorination by approximately
600-fold (Figure 8) and nearby histidine residues also appear to favor tyrosine
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Figure 9: Summary of Reactions by HOCl that Compete with 3ClTyr Formation. All
rate constants are for individual amino acid analogues. The rate constants for HOCl or
chloramines reacting with sulfur containing amino acids or glutathione and primary amines
reacting with HOCl are published elsewhere.31, 34 The remaining rate constants are from
Table 1.
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chlorination.43, 48, 66, 67 The maximal rate enhancement is likely higher than that observed
here when a less flexible polypeptide backbone and an optimal position of the chloramine
relative to the phenol ring are present, warranting further investigation.
The kinetics of AcTyr or Ac3ClTyr by HOCl is pH dependent (Figure 7) and
phenolate is more rapidly chlorinated by HOCl as expected for an electrophilic aromatic
substitution reaction. The phenolate form is approximately 25- to 400-fold more rapidly
chlorinated than the phenol form of AcTyr; the uncertainty in this rate enhancement is
because the data did not allow us to discriminate between hypochlorous acid reacting
with the phenolate and the phenol reacting with hypochlorite. A possible explanation of
the effect of neighboring histidine or lysine residues on the kinetics of tyrosine
chlorination is that these basic residues lower the pKa value of tyrosine, accelerating the
reaction kinetics. However, the apparent rate enhancement of tyrosine in the context of a
peptide can be over 500-fold, suggesting that this alternate explanation is not the major
reason for selective chlorination of tyrosine residues near lysine or histidine.
Furthermore, the pKa value of the phenol group in the peptide was no different than that
of AcTyr, eliminating this possible mechanism of enhanced kinetics in our model.
The equilibrium between HOCl and Cl2, another chlorinating agent present at
acidic pH values in the presence of chloride ions, could influence the in vivo kinetics of
tyrosine chlorination. While chloride had no significant effect on tyrosine chlorination at
the neutral pH values (Figure 7) found in blood and most human tissue, a significant
increase in tyrosine chlorination kinetics is expected in the stomach given its acidic pH
and high chloride concentration, as observed in the stomach of rats.68 Modeling the effect
of chloride concentration on tyrosine chlorination indicated that the rate enhancement
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was approximately equal to the published rate of Cl2 formation.53 The actual rate of
tyrosine chlorination by Cl2 was not accessible by the experiments described here, but is
expected to be approximately 100-fold faster given its kinetics with phenol.69
Most reports that measure 3ClTyr from in vivo tissues did not also measure
Cl2Tyr. However, other reports that measured both 3ClTyr and Cl2Tyr observed
quantities of Cl2Tyr approaching the quantity of 3ClTyr observed.61, 64, 70 The nasal tissue
of Fisher 344 rats exposed to chlorine gas resulted in equal quantities of 3ClTyr and
Cl2Tyr;70 this result could be due to the different mechanism, relative to HOCl, of
tyrosine chlorination by Cl2.69 Of more relevance to the in vivo kinetics of HOCl is the
observation of Cl2Tyr in both bacterial and neutrophil proteins where up to one third of
chlorinated tyrosine residues were Cl2Tyr.64 The observation of 3ClTyr in the sputum of
asthmatic subjects was not significantly different than that of normal controls, however,
Cl2Tyr was significantly elevated.61 The chemical reaction and rate constants reported
here indicate that the formation of 3ClTyr is limited by the formation of Cl2Tyr with
exposure to significant quantities of HOCl. In control tissues with activated neutrophils,
Cl2Tyr formation may be a better biomarker of disease processes.
The above predictions based on rate constants reported here indicate that
formation of the free amino acid Cl2Tyr is not likely. However, the limited reports
measuring protein-bound Cl2Tyr in biological tissue further suggest that the formation of
protein-bound Cl2Tyr is more likely and could prove important in unraveling questions
concerning physiological relevant levels of HOCl synthesis.
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Abstract
The markers 3-nitrotyrosine and 3-chlorotyrosine are measured as surrogates for
reactive nitrogen species and hypochlorous acid, respectively, which are both elevated in
inflamed tissues of humans. However, a previous study1 observed that 3-nitrotyrosine is
lost when exposed to hypochlorous acid suggesting that 3-nitrotyrosine underestimates
the reactive nitrogen species present in diseased tissues when 3-chlorotyrosine is also
present. This study evaluates the significance of this qualitative finding by measuring the
kinetics of 3-nitrotyrosine loss upon reaction with hypochlorous acid. The results
demonstrate that 3-nitrotyrosine is chlorinated by hypochlorous acid or chloramines to
form 3-chloro-5-nitrotyrosine. As 3-nitrotyrosine from in vivo samples is usually found
within proteins, as opposed to the free amino acid, we also examined the reaction of 3nitrotyrosine loss in the context of peptides. The chlorination of 3-nitrotyrosine in
peptides was observed to occur up to 700 fold faster than control reactions using
equivalent amino acid mixtures and depended on the peptide sequence. The chlorination
in peptides whereby the rapid intermolecular formation of a peptide chloramine is
followed by a slower intramolecular chlorination of 3-nitrotyrosine is supported by the
observed first order kinetics of chlorination during the rate limiting intramolecular
reaction. These results further advance our understanding of the chloramine-dependence
of tyrosine chlorination in peptides improving the ability to predict likely damage sites in
proteins.
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Introduction
Reactive chemicals are implicated in the pathology of human diseases associated
with aberrant or chronic inflammation including cancer, neurodegenerative diseases, and
cardiovascular disease.2-5 The innate immune cells recruited to inflamed tissues by
cytokines express enzymes that catalyze the synthesis of these reactive chemicals.6-11
Myeloperoxidase catalyzes the oxidation of chloride ions by hydrogen peroxide to form
hypochlorous acid (HOCl) that damages biological molecules including tyrosine free in
solution and tyrosine residues in proteins to form 3-chlorotyrosine (3ClTyr).12, 13 Reactive
nitrogen species, such as peroxynitrite and nitrogen dioxide formed when nitric oxide is
oxidized, damage biological molecules such as free or protein-bound tyrosine to produce
3-nitrotyrosine (NO2Tyr).5 The markers NO2Tyr and 3ClTyr are measured as surrogates,
respectively, of reactive nitrogen species and HOCl formed in vivo because these tyrosine
damage products are chemically stable and readily measured with existing analytical
methods.14-17 One study, however, demonstrated in vitro that NO2Tyr is lost in the
presence of HOCl suggesting that the observed NO2Tyr underestimates the levels of
reactive nitrogen species in tissues that also produce HOCl.1
The coincident formation of reactive halogen and reactive nitrogen species occurs
when the enzymes myeloperoxidase and nitric oxide synthase are both present.
Myeloperoxidase can consume nitric oxide in the presence of hydrogen peroxide and
generate reactive nitrogen species capable of nitrating tyrosine residues to form
NO2Tyr.18, 19 Resting human neutrophils isolated from peripheral blood do not normally
express inducible nitric oxide synthase (iNOS).7 However, activated neutrophils exposed
to cytokines can express iNOS, produce nitric oxide, and increase the level of reactive
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nitrogen species suggesting that recruitment of neutrophils during inflammation can
increase both tyrosine nitration and chlorination. Some populations of tissue
macrophages, notably those found in atherosclerotic plaques and the brain, contain both
iNOS and myeloperoxidase.7 The observation of both 3ClTyr and NO2Tyr in diseased
tissues of patients with atherosclerosis, cardiovascular disease, or neurodegeneration
confirms the presence of active MPO in tissues with reactive nitrogen species.11, 20, 21
The kinetics of NO2Tyr reacting with HOCl or HOCl-derived chloramines is
important for estimating the loss of the marker NO2Tyr in vivo when both reactive
nitrogen species and active myeloperoxidase are present. The kinetics reported here
include the direct reaction of HOCl or chloramines with NO2Tyr and the reaction of
HOCl to form a peptide-bound chloramine followed by indirect chlorination of a nearby
NO2Tyr residue. The product of NO2Tyr chlorination, 3-chloro-5-nitrotyrosine
(ClNO2Tyr), is also reported. Comparison of the intramolecular and intermolecular
chlorination kinetics of NO2Tyr by chloramines indicates that the indirect chlorination of
tyrosine residues is accelerated relative to the otherwise slow intermolecular rates for free
amino acids. The relevance of these results to the chlorination of tyrosine residues to
form the biomarker 3ClTyr is discussed.

Experimental Procedures
Materials
N-Acetyl-L-tyrosine (AcTyr), N-α-acetyl-L-lysine (AcLys), and N-acetyl-Lhistidine (AcHis) were purchased from Novabiochem (San Diego, CA). FMOC-amide
resin was purchased from Applied Biosystems, Inc. (Foster City, CA). FMOC-OSu,
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FMOC-Lys(BOC)-OH, FMOC-His(Trt)-OH, and all other FMOC amino acids were
purchased from Advanced ChemTech (Louisville, KY), with the exception of FMOCTyr(NO2)-OH which was synthesized as described below. All other laboratory chemicals
were purchased from Sigma-Aldrich (St. Louis, MO).

Synthesis of N-acetyl-3-nitrotyrosine
3-Nitro-L-tyrosine was acetylated with excess acetic anhydride in acetone at room
temperature (Figure 1). After reacting overnight, the product, N-acetyl-3-nitrotyrosine
(AcNO2Tyr), was formed and found soluble in acetone. The acetone was evaporated by
use of a rotary evaporator and any remaining acetic anhydride was hydrolyzed by the
addition of water. The solution was added to a SupelClean, LC-18 packing, solid phase
extraction (SPE) column (Supelco, Bellefonte, PA). The column was washed with 0.1%
trifluoroacetic acid (TFA) and subsequent washes were composed of increasing
concentrations of methanol (5% increments) in 0.1% TFA. Aliquots were analyzed by
analytic HPLC to determine the purity and fractions > 98% pure were combined and
lyophilized. The compound gave the expected UV/vis maximums at 279 nm and 360
nm.22 The 1H-NMR spectra is consistent with AcNO2Tyr. 1H-NMR (500 MHz, DMSO):
12.72 (s, 1H, -CO2H ), 10.79 (s, 1H, -OH), 8.18 (d, J = 8.1 Hz, 1H, NH), 7.74 (d, J = 2.0
Hz, 1H, H2), 7.41 (dd, J = 2.0, 8.5 Hz, 1H, H6), 7.05 (d, J = 8.5 Hz, 1H, H5), 4.38 (m,
1H, Hα), 3.01 (dd, J = 4.7, 13.9 Hz, 1H, Hβ), 2.80 (dd, J = 9.4, 13.9 Hz, Hβ), 1.78 (s, 3H,
CH3).
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A. Synthesis of Ac3ClTyr

B. Synthesis of AcCl2Tyr

Figure 1: Synthesis of AcNO2Tyr and AcClNO2Tyr. AcNO2ClTyr was synthesized by
acetylation of NO2Tyr with excess acetic anhydride (Ac2O) (A). AcClNO2Tyr was
synthesized by acetylation of 3ClTyr with subsequent nitration by excess sodium nitrate in
sulfuric acid (B).
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Synthesis of N-acetyl-3-chloro-5-nitrotyrosine
3-Chloro-L-tyrosine (3ClTyr) was acetylated as described previously. The crude
product, N,O-diacetyl-3-chlorotyrosine, was produced after an overnight reaction and is
soluble in acetone. The acetone was evaporated and the crude compound was then
dissolved in water. Excess sodium nitrate (approximately 3-fold) was added, the solution
was placed on ice, and then concentrated sulfuric acid was added dropwise to hydrolyze
the phenol acetate ester and nitrate the phenol giving N-acetyl-3-chloro-5-nitrotyrosine
(AcClNO2Tyr) (Figure 1). The solution was allowed to react for two hours before being
purified by SPE as described above. Analytical HPLC showed the final purity was >
98%. The UV/vis spectrum shows maximums at 285 nm and 358 nm under acidic
conditions. The 1H-NMR is consistent with AcClNO2Tyr. 1H-NMR (500 MHz, DMSO):
12.77 (s, 1H, -CO2H), 10.91 (s, 1H, -OH), 8.21 (d, J=8.3 Hz, 1H, NH), 7.79 (d, J = 2.0
Hz, 1H, H6), 7.70 (d, J = 2.0 Hz, 1H, H2), 4.43 (m, 1H, Hα), 3.05 (dd, J = 4.8, 13.8 Hz,
1H, Hβ), 2.83 (dd, J = 9.7, 13.8 Hz, 1H, Hβ), 1.80 (s, 3H, CH3).

Synthesis of N-FMOC-3-nitrotyrosine
An FMOC protecting group was added to the N-terminus of NO2Tyr by reacting
with equimolar FMOC-OSu and 3-fold excess sodium bicarbonate in a 50:50 mixture of
water and acetone. After stirring overnight at room temperature, the aqueous layer was
extracted four times with diethyl ether. The combined diethyl ether solution was backextracted twice with a 5% sodium bicarbonate solution. The combined aqueous layers
were acidified by adding concentrated HCl until precipitate formed. The product was
extracted with ethyl acetate twice, combined, and dried using anhydrous magnesium
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sulfate. Finally, the solvent was removed by rotary evaporation, leaving a golden powder
for use in peptide synthesis.

Peptide Synthesis and Purification
Peptides containing histidine or lysine residues in close proximity to the NO2Tyr
residue were synthesized on an ABI model 433A peptide synthesizer using fast FMOC
chemistry. Following synthesis, the N-terminus was acetylated using acetic anhydride.
The protecting groups and resin support were cleaved from the peptides using a mixture
of TFA/phenol/water/triisopropylsilane (88:5:5:2). The resin was removed by filtration,
the cleavage reaction was concentrated by rotary evaporation, and then the peptide was
precipitated by adding cold diethyl ether to the cleavage mixture. The ether was removed
following centrifugation to pellet the precipitated peptide. After washing the crude
peptide with cold diethyl ether three times, the peptides were purified by reverse phase
HPLC using a C18 column (Varian Dynamax, 250 mm x 21.4 mm, 300 Å, 5 µM) with a
gradient of 20 - 60% mobile phase B (acetonitrile with 0.085% TFA) where mobile phase
A contained aqueous 0.1% TFA. The sequence of the purified peptides was confirmed by
MS/MS using a ThermoFinnigan LCQ Deca XP mass spectrometer, and a purity of >
95% was verified by analytical HPLC.

Methods
The purchased sodium hypochlorite stock was stored at 4 °C. The pKa of HOCl is
7.5 resulting in almost equal concentrations of hypochlorous acid and its conjugate base,
hypochlorite, at physiological pH. The term “hypochlorous acid” is thus used to refer to
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both the acid and its conjugate base. The concentration of the sodium hypochlorite stock
was determined daily using the absorbance at 290 nm (ε290 nm = 350 M-1cm-1) for a fresh
dilution of the stock into 0.1 M NaOH.23 Dilutions of HOCl stock were then made into 20
- 200 mM phosphate buffer. The stock concentrations of NO2Tyr or AcClNO2Tyr
containing chemicals were determined following dilution into 0.1 M HCl and using
UV/vis spectroscopy with molar absorptivity values of ε360 nm= 2790 M-1cm-1 and ε358 nm=
2496 M-1cm-1, respectively. The molar absorptivity value of ClNO2Tyr was determined
as a ratio of the published value for NO2Tyr by mixing AcClNO2Tyr and AcNO2Tyr
stock solutions with known UV spectra, vacuum centrifuging to remove water, dissolving
in deuterated DMSO, collecting a 1D NMR spectrum, and calculating the ratio of both
compounds based on pairs of integrated peaks corresponding to the same resonance.22

Reactions of AcNO2Tyr with HOCl or Chloramines
All reactions contained 200 μM HOCl, 400 – 1000 μM AcNO2Tyr, and 100 mM
phosphate buffer at the indicated pH. For reactions with lysine or histidine chloramines,
five-fold excess AcLys or AcHis was added to the AcNO2Tyr solution before the
addition of HOCl. Previous studies pre-formed the chloramine by addition of HOCl to
AcHis,23 but when comparing techniques, there was no significant difference in
ClNO2Tyr product formation. Reactants were mixed in 1.5 mL glass vials in an
aluminum block maintained at 37 °C with stir bars in the reaction vessels. All reactions
with HOCl or chloramines were quenched with 10-fold excess methionine or cysteine,
respectively, at time points ranging between 5 seconds and 2 hr.
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UV/Vis Spectroscopy of AcClNO2Tyr Chlorination by HOCl
The UV-spectra of AcClNO2Tyr reacting with HOCl was measured on a Varian
(Palo Alto, CA) Cary 100 Bio UV/vis spectrophotometer in a 1-cm micro quartz cell.
AcClNO2Tyr (185 µM) was reacted with 720 µM HOCl at 37 ºC and the spectra between
350 and 550 nm were measured every 24 seconds.

Reaction of Peptides with HOCl
HOCl was reacted with excess peptide at 20 – 240 µM peptide and 10 - 120 µM
HOCl in 10 mM phosphate buffer at the indicated pH. Reactants were rapidly mixed in a
1.5 mL glass vials in an aluminum block at 37 ºC and quenched with 10-fold excess of
cysteine at time points between 5 seconds and 12 hr.

HPLC Quantitation of Reaction Products
The concentration of products and reactants in kinetic samples were measured
using a ThermoFinnigan (Waltham, MA) Surveyor HPLC system with a MS Pump,
Autosampler, and PDA detector (200-600 nm). Standard curves were generated using
stocks (> 98% pure) of AcNO2Tyr and AcClNO2Tyr (r2 > 0.999). Separation of each
analyte was accomplished using a Restek Ultra IBD column (C18, 3 μm, 150 x 2.1 mm).
The initial solvent mix was 95% mobile phase A (0.1% TFA in water) and 5% mobile
phase B (0.085% TFA in acetonitrile) for 5 min followed by a linear gradient to 50%
mobile phase B over 20 min at a flow rate of 100 μL/min. The gradient stayed constant
for 2.5 min followed by a linear decrease to 5% B in 2.5 min. The limit of detection (S/N
> 3) was ≈ 0.1 μM while the limit of quantitation was approximately 120 μM for each
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analyte. Kinetics samples were diluted as necessary to achieve a final concentration of
AcNO2Tyr and AcClNO2Tyr less than the limit of quantitation. AcNO2Tyr and
AcClNO2Tyr were quantitated at 360 nm. The Qual browser module of Xcalibur, ver. 1.3
(Thermo-Finnigan, Ontario, Canada) was used to analyze the HPLC chromatogram.
Standard curves using AcNO2Tyr and AcClNO2Tyr were obtained regularly to ensure
accuracy of measured concentrations.

Determination of Initial Reaction Rate and Reaction Order
The lysine-containing peptides were reacted with HOCl and quenched with excess
cysteine at 37 °C in 10 mM phosphate buffer at pH 7.4. Four or five time points were
chosen in which the product formation was less than 20% of the initial HOCl
concentration. The reported initial reaction rate of NO2Tyr chlorination, V0, was
determined as the slope of product formation with respect to time that is by a linear line.
The V0 of 12-15 reactions with various initial concentrations of peptide and HOCl were
used to solve for the reaction order using the equation V0 = k * [Peptide]0A *
[Chloramine]0B, where A and B are the rate order of peptide and chloramine,
respectively. Because HOCl reacts with lysine forming a chloramine significantly faster
than any measurable formation of ClNO2Tyr, the initial concentration of chloramine
peptide is equivalent to the initial concentration of HOCl.25

Analysis of Kinetics Data and Determination of Rate Constants
Microsoft Excel was used to analyze all kinetic data using a model comparison
method.26 A time interval of 0.1 seconds was used to numerically model the differential

65

equations. The chemical models for chlorination of NO2Tyr by HOCl or chloramines are
presented in the Results section. The sum of the squared differences (SSD) was
calculated between the experimental and modeled concentrations for time points in a
kinetics experiment. The Solver tool in Excel was used to determine the optimized
second order rate constants that minimized the SSD giving SSDopt. The error in each rate
constant was estimated by determining the rate constant that gave SSD =
SSDopt*(F(P/(N-P))+1) where F is the critical value of the F distribution, P is the number
of model parameters, and N is the number of data points. We chose a value of F
corresponding to the 95% confidence level. The rate constant values are reported as
middle value ± ½*range; the middle value was calculated from the high and low SSD
values that defined the range of certainty (95% confidence level) and were within 1% of
the optimized value in all cases.

Results
HOCl Reacts with NO2Tyr to Form ClNO2Tyr
The published chlorination of 3-substituted tyrosine analogues by HOCl
suggested that the loss of 3-nitrotyrosine observed previously resulted in the formation of
3-chloro-5-nitrotyrosine.1, 27 To avoid the competing reaction of HOCl with the amino
group of 3-nitrotyrosine, the acetylated analogues of NO2Tyr and ClNO2Tyr were
synthesized.28 The 1H-NMR and UV/vis spectra were consistent with the expected
structure and HPLC indicated that the purified compounds were > 98% pure. The pKa
values of AcNO2Tyr and AcClNO2Tyr were determined by UV/vis spectroscopy to be
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7.1 ± 1 and 5.4 ± 1, respectively (Appendix D). The pKa of AcNO2Tyr is comparable to
the previously published pKa value of NO2Tyr (7.2-7.5).29
The reaction of AcNO2Tyr with HOCl to form AcClNO2Tyr was monitored by
HPLC. All reactions were initiated by adding HOCl in concentrated buffer (200 mM, pH
of 7.4) to equal volumes of the AcNO2Tyr in purified water with and without excess
AcHis or AcLys present. The reactions were stopped by adding a minimum 10-fold
excess methionine or cysteine which rapidly reacts with any remaining HOCl or
chloramine, respectively.24, 25, 30 Figure 2 shows the formation of AcClNO2Tyr after a
30-second reaction of AcNO2Tyr with HOCl. The observed product peak had the same
retention time and UV spectra as observed for the authentic standard of AcClNO2Tyr.
We monitored the reactions between AcNO2Tyr and HOCl, N-acetylhistidine
chloramine (AcHisCl), or N-α-acetyllysine chloramine (AcLysCl) at pH 7.4 and 37 °C
between 5 seconds and 120 min. AcNO2Tyr at concentrations of approximately 500, 750,
and 1000 μM were reacted with 200 μM HOCl both in the presence and absence of
excess AcHis or AcLys. The reaction of 750 µM AcNO2Tyr with 200 µM HOCl (Figure
3a) or AcHisCl (Figure 3b) results in AcClNO2Tyr production. The reaction with
AcLysCl was too slow to produce any measureable amount of AcClNO2Tyr after two
hours but product was seen the next day (data not shown). In all cases, the total amount
of AcClNO2Tyr produced was less than the initial amount of HOCl, suggesting that
HOCl further reacts with AcClNO2Tyr to form compounds without UV absorbance at
wavelengths longer than 200 nm.27 Due to this apparent reaction, only the early time
points where the AcClNO2Tyr concentration was less than 30% of the initial HOCl
concentration were modeled to calculate the rate constants. One possible explanation as
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Figure 2: Separation and Quantitation of AcNO2Tyr and AcClNO2Tyr by HPLC.
AcClNO2Tyr is formed after 500 μM AcNO2Tyr is reacted with 200 μM HOCl at 37 °C,
pH 7.4. The reaction was stopped by the addition of excess methionine after 30 s. The
peaks at 22.8 and 25.7 min have identical UV spectra and retention times as authentic
standards of AcNO2Tyr and AcClNO2Tyr, respectively.
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A. AcNO2Tyr + HOCl
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Figure 3: Kinetics of AcNO2Tyr Chlorination by HOCl or AcHisCl. (A) 780 µM
AcNO2Tyr or (B) 730 µM AcNO2Tyr with 1000 µM AcHis were reacted with 200 µM
HOCl at 37 °C for the indicated time; the reaction was stopped with excess methionine,
and the products were quantitated by UV-detected HPLC. The solid lines in each panel
represent the modeled reaction progress with optimized rate constants. The rate constant k1
for AcNO2Tyr reacting with HOCl in panel A is 24.5 M-1s-1. The rate constant k1 for
AcNO2Tyr reacting with AcHisCl in panel B is 1.0 M-1s-1. Similar experiments were done
for AcLysCl but no product was measured after two hours of reaction.
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to the loss of chlorinating potential is the degradation and loss of AcHisCl as previously
reported.30 However, even tripling the reported rate of AcHisCl degradation and
incorporating that into our model, we saw no significant change in our rate constant or the
available amount of AcHisCl during the earlier time points. The complete set of data for
AcNO2Tyr reacting with HOCl or AcHisCl was modeled to obtain a single set of rate
constants, summarized in Table 1.

HOCl Reacts with AcClNO2Tyr to Form Unknown Products
We investigated the reaction of AcClNO2Tyr with HOCl by HPLC and UV/vis.
No product peaks were identified by UV-HPLC and the measured loss of AcClNO2Tyr
was less than the initial HOCl introduced. This would seem to indicate that an unknown
product with no significant UV/vis chromophore forms and that it reacts more readily
with HOCl than AcClNO2Tyr. We followed the loss of AcClNO2Tyr in the presence of
HOCl by UV/vis at 37 °C, pH 7.4 (Figure 4). The rate of loss of AcClNO2Tyr decreases
as the reaction progresses, indicative of the unknown products being able to successfully
compete with AcClNO2Tyr for reaction with HOCl. It takes approximately 6-fold excess
HOCl to completely degrade AcClNO2Tyr (data not shown). Possible products could be
chlorinated ketones and chloroform, as seen when phenol analogues are reacted with
excess HOCl,31 but as the focus of this report is the physiological significance of NO2Tyr
loss, we did not identify the unknown products or reaction kinetics when ClNO2Tyr
reacts with HOCl.
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Table 1: Rate Constants for Chlorination of Tyrosine, 3ClTyr, and NO2Tyr.a

Chlorinating
Species

AcTyrb
(M-1s-1)

Ac3ClTyrb
(M-1s-1)

AcNO2Tyr
(M-1s-1)

HOCl

71 ± 8

238 ± 27

24.5 ± 1.2

HisCl

3.0 ± 0.3

10.4 ± 1.0

1.1 ± 0.2

LysCl

0.004 ± 0.003

0.008 ± 0.002

NDc

a

Reactions were performed at 37 ºC, pH 7.4 in 100 mM phosphate buffer.
Rate constants were reported previously in reference 27.
c
No significant amount of product was detected after two hours of reaction.
b
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A. UV/vis Spectrum of AcClNO2Tyr + HOCl
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Figure 4: UV/Vis Analysis of AcClNO2Tyr Reacting with HOCl. (A) UV spectrum of
185 μM AcClNO2Tyr reacting with 720 μM HOCl at 37 °C, pH 7.4. The initial spectrum
is shown as a bold line while the arrow shows the changes in the spectra collected every
subsequent 24 s. (B) The consumption of 185 μM AcClNO2Tyr by 720 μM HOCl at 37
°C, pH 7.4. The concentration of AcClNO2Tyr was based on the absorbance at 430 nm and
a molar absorptivity value of ε430 = 4205 M-1cm-1. The change in the rate of AcClNO2Tyr
degradation indicates multiple reactions going on, likely between HOCl and the product of
AcClNO2Tyr chlorination. It takes approximately six-fold excess HOCl to completely
degrade AcClNO2Tyr (data not shown).
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Rate of NO2Tyr Chlorination by HOCl Increases in Peptides
Previous studies indicate that chlorination of tyrosine residues in polypeptides is
facilitated by nearby histidine or lysine residues.24, 27, 32 We reacted the synthetic peptide,
Ac-HGNY(NO2)AE-NH2, with a 0.5-fold concentration of HOCl and followed product
formation by HPLC as shown in Figure 5. An amino acid mixture of N-acetyl amino
acids that match the residue composition of the peptide Ac-HGNY(NO2)AE-NH2 was
also reacted with 0.5-fold concentration of HOCl as a control reaction (Figure 5). The
reactions were quenched with excess cysteine at various time points and the peptide
reactants and products were quantitated by HPLC. The production of ClNO2Tyr in the
peptide was approximately 700-fold faster than in the amino acid mixture at the
concentrations and reaction conditions examined.

NO2Tyr Chlorination by HOCl in Peptides is a First Order Reaction
To probe the mechanism whereby neighboring lysine or histidine residues facilitate
NO2Tyr chlorination, we varied the peptide and HOCl concentrations to determine the
order of the reaction kinetics. The initial reaction kinetics were measured to minimize the
effect of ClNO2Tyr reacting with HOCl or chloramines. Initial experiments found that the
reaction kinetics were independent of the initial peptide concentration and changed only
with the amount of HOCl. The reaction kinetics shown in Figure 6 indicate that the
kinetics are first order with respect to chloramine-containing peptide concentration which
is equivalent to the amount of HOCl. Given the rapid reaction of HOCl with a peptide
amine that is complete within 1 second, the reaction is first order with respect to
chloramine concentration provided the peptide is present in excess. The rate constants of
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Figure 5: Acceleration of NO2Tyr Chlorination by His Chloramine in a Peptide. 75
µM Ac-HGNY(NO2)AE-NH2 or an analogous amino acid mixture were reacted with 37.5
µM HOCl at 37 °C for the indicated times; the reaction was stopped with excess cysteine
and the products were quantitated by UV-detected HPLC. At the concentrations indicated
here, the rate of NO2Tyr chlorination in the peptide is approximately 700-fold faster than
in the analogues amino acid mixture.
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A. Intramolecular – First Order
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Figure 6: Determining the Rate Order of NO2Tyr Chlorination by Chloramines
within a Peptide. Excess Ac-KGNY(NO2)AE-NH2 was reacted with HOCl at 37 ºC, pH
7.4. The initial reaction rate was determined by using HPLC to measure the formation of
ClNO2Tyr at early time points where less than 20% of the reactant peptide was consumed.
Samples were quenched with excess cysteine before HPLC. The initial reaction rate was
calculated by linearly fitting the early time points. Because the reaction of Lys with HOCl
is significantly faster than the chlorination of NO2Tyr, it was assumed that the
concentration of peptide containing lysine chloramine was equal to the amount of HOCl
added. The initial reaction rate was plotted to (A) the concentration of AcK(Cl)GNY(NO2)AE-NH2 to model a first-order reaction and to (B) the square of the
concentration of this peptide to model a second-order reaction. The linearity of the firstorder fit indicates that NO2Tyr is chlorinated through an intramolecular reaction with the
lysine chloramine.
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NO2Tyr chlorination by chloramine intermediates in the peptides we synthesized in this
study are summarized in Table 2.

Discussion
Reactive nitrogen species (RNS) chemically damage tyrosine residues to form 3nitrotyrosine (NO2Tyr), a surrogate marker used to investigate the role of RNS in human
diseases. However, Whiteman and Halliwell reported that NO2Tyr disappears when
exposed to HOCl suggesting that observed NO2Tyr underestimates the role of RNS in
tissues when chlorinating species are also present.1 That study did not report the resulting
product when NO2Tyr reacts with HOCl, but subsequent studies on the reaction of HOCl
with 3ClTyr to form Cl2Tyr suggested that the expected product should be ClNO2Tyr.27,
33-35

This expectation is now confirmed since reaction of AcNO2Tyr with HOCl forms a

new product that has the same HPLC retention time and UV-spectra as authentic
AcClNO2Tyr (Figure 2).
The extent of NO2Tyr loss depends on the quantity of HOCl produced and the
kinetics of NO2Tyr chlorination. The kinetics of AcNO2Tyr reacting with HOCl or
chloramines were accurately determined by HPLC (Figure 3) and are reported in Table
1. While the kinetics of 3ClTyr reacting with HOCl or a histidine chloramine are
approximately three times faster than tyrosine chlorination, the kinetics of NO2Tyr
chlorination are three times slower. The 3-nitro groups on chlorination kinetics is
consistent with an electrophilic aromatic substitution reaction where the kinetics of
chlorination are slower due to the electron withdrawing groups deactivating the aromatic
ring. The kinetics of chlorination is affected by pH with maximum rates at pH values of
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Table 2: Rate Constants for Chlorination of Tyr and NO2Tyr within a Peptidea

a

Peptide Sequence

Rate Constant (s-1)

pKa

Ac-HGN-Y(NO2)-AE-NH2

2.60 ± 0.53 x 10-2

6.9 ± 0.1

Ac-KGN-Y(NO2)-AE-NH2

2.54 ± 0.03 x 10-5

6.9 ± 0.1

Ac-KGN-Y-AE-NH2

2.38 ± 0.07 x 10-4

9.8 ± 0.1

Reactions were performed at 37 ºC, pH 7.4 in 10 mM phosphate buffer.
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7.4 and 8.0 for NO2Tyr (Appendix E) and 3ClTyr, respectively.27 The faster kinetics of
chlorination at these pH values is consistent with an electrophilic aromatic substitution
reaction where a phenolate is more reactive than a phenol.
As observed with Cl2Tyr,27 ClNO2Tyr also reacts with HOCl to form multiple
compounds without a UV spectrum as shown in Figure 4. The reaction of ClNO2Tyr
with chlorinating compounds to form compounds with no UV absorption explains the
apparent loss of tyrosine analogues observed by UV-detected HPLC at longer reaction
times and/or higher ratios of chlorinating agent relative to tyrosine analogue. The
reported kinetics rates used excess NO2Tyr and were calculated using earlier reaction
times where the loss of ClNO2Tyr was not observed.
Measurements of 3ClTyr or NO2Tyr from biological tissues usually measure these
surrogate markers in the context of proteins instead of the free amino acid. The
observation that tyrosine residues with a nearby histidine or lysine residues are
preferentially chlorinated is better explained by the intramolecular reaction with a nearby
chloramine than the direct intermolecular chlorination by HOCl to form a protein-bound
3ClTyr.24, 27, 33, 35, 36 The fast reaction of HOCl with protein amines (~105 M-1s-1) better
competes with the antioxidant glutathione (~108 M-1s-1) than the direct chlorination of
tyrosine analogues (~102 M-1s-1) and explains the preferential chlorination of some
protein-bound tyrosine residues, provided the intramolecular kinetics are sufficiently
fast.25, 32
The rates of tyrosine, 3ClTyr, or NO2Tyr chlorination by a histidine chloramine in
Table 1 are 24-fold slower than the reaction with HOCl. However, the rate of NO2Tyr
chlorination by HOCl is 700-fold faster in the peptide Ac-HGNY(NO2)AE-NH2 than an
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equivalent amino acid mix containing AcNO2Tyr and Ac-His (Figure 5). We argue that
this increased rate of chlorination is due to the reduced degrees of freedom and close
proximity maintained between the histidine chloramine and the NO2Tyr residues in the
peptide context. The rapid intermolecular reaction of HOCl with a polypeptide amine to
form a chloramine followed by the slower intramolecular chlorination of a nearby
tyrosine analogue predicts that the kinetics of peptide tyrosine chlorination will follow
first order kinetics. To our knowledge, this study is the first to demonstrate that the
kinetics of tyrosine chlorination in a peptide with nearby amine follows first order
kinetics (Figure 6).
The second order kinetics of AcTyr or N-acetyl-3chlorotyrosine (Ac3ClTyr)
chlorination by lysine chloramines is approximately 1000 times slower than chlorination
by histidine chloramines.27 Likewise, the first order kinetics of NO2Tyr chlorination in a
peptide by a lysine chloramine is 1000 times slower than a histidine chloramine (Table
2). Figure 7 shows the intermolecular and intramolecular reaction schemes used in this
report to extract first and second order rate constants. It should be noted that AcHisCl
and, to a lesser extent, AcLysCl naturally decompose,30, 37 but this rate was not
incorporated into our model since it had no significant effect at the concentrations and
time points used in this study.
Given the slow intermolecular kinetics of NO2Tyr chlorination, the loss of
NO2Tyr in proteins due to HOCl likely requires a nearby lysine or histidine residue. For
example, Tyr192 of apolipoprotein A-1 can be nitrated or chlorinated suggesting that
measurements of Tyr192 nitration will underestimate RNS when HOCl is present.38
However, selective tyrosine nitration is reported to have different sequence requirements
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A. Intermolecular Scheme

B. Intramolecular Scheme

Figure 7: Kinetics Schemes for the Chlorination of NO2Tyr by HOCl. (A) HOCl
converts AcNO2Tyr to AcClNO2Tyr which is consumed when exposed to HOCl or
chloramines to form unknown products. (B) When NO2Tyr is on a peptide containing a
nearby lysine or histidine, the amine is first rapidly chlorinated by HOCl in an
intermolecular reaction. The rate of chloramine formation by HOCl, k3, is much greater
than the direct chlorination of NO2Tyr by HOCl, k1. The peptide chloramine then
chlorinates NO2Tyr in an intramolecular reaction to form ClNO2Tyr.
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than selective tyrosine chlorination suggesting that loss of NO2Tyr in the presence to
HOCl will depend on the specific tyrosine residue examined.39-42 It should be
acknowledged that with the low rate of NO2Tyr chlorination by HOCl, it is unlikely that
the product, ClNO2Tyr, would be important physiologically. Of greater concern is the
loss of 3ClTyr in the presence of HOCl, since the same sequence characteristics, a nearby
histidine or lysine, favor tyrosine chlorination as well as 3ClTyr chlorination to Cl2Tyr.
While most studies only measure 3ClTyr, some reports that measure 3ClTyr and Cl2Tyr
find significant quantities of both chlorination products when the quantity of 3ClTyr is
consistent with the quantities observed in vivo indicating that published 3ClTyr levels and
may underestimate the extent of HOCl production.27, 34, 35, 43, 44 Future measurements of
3ClTyr should also include Cl2Tyr in order to better estimate the extent of HOCl
production in vivo.
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Abstract
The molecule 3-chlorotyrosine (3ClTyr), formed when hypochlorous acid (HOCl)
chlorinates tyrosine, is a biomarker of inflammation. HOCl can also chlorinate histidine
or lysine side-chains creating chloramines. It has been postulated previously that 3ClTyr
formation in vivo is predominantly through chloramine intermediates, as evidenced by the
increased incidence of chlorination of tyrosine residues that are nearby histidine or lysine
residues in a protein. While previous studies have shown how yields of 3ClTyr change
depending on the positioning of lysine with respect to tyrosine in a peptide, they have
failed to measure the change in the rate of chlorination. In this study, we use linear
peptide sequences containing 3-nitrotyrosine (NO2Tyr) and lysine at different positions to
explore the effect this has on the rate of chlorination of the tyrosine analogue. We also
synthesized and characterized a cyclic ten-residue peptide designed to structurally
constrain tyrosine and lysine residues nearby in space to better facilitate chlorination. In
simple linear peptides, the rate of chlorination changes based on the position of lysine to
tyrosine such that KxY > KY > KxxY > KxxxY, where x represents a residue that is
unreactive with HOCl. The rate of chlorination is further increased if the secondary
structure constricts lysine and tyrosine nearby in space, as determined in the gramicidin S
analogue cyclo-P(OH)TKLDFP(OH)TYLDF. The intramolecular rate constants of
tyrosine chlorination for all synthesized peptides are reported and the results discussed in
relation to previous literature.
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Introduction
Hypochlorous acid (HOCl) is the primary reactive oxygen species (ROS)
produced by activated neutrophils at sites of inflammation. Phagocytic leukocytes,
including neutrophils, monocytes, and macrophages, all generate reactive oxygen and
chlorine species to kill invading microorganisms or in the clearance of damaged tissue.1, 2
In humans, the production of HOCl is unique to the activity of the enzyme
myeloperoxidase (MPO) which utilizes hydrogen peroxide (H2O2) and chloride ions to
generate this reactive species.3
While the generation of HOCl is typically confined to vesicles containing
engulfed bacteria,4, 5 reactive species produced by phagocytes can also cause damage to
host tissues.3, 6 For example, neutrophils can actively secrete MPO into the extracellular
environment and disruption in enzyme trafficking can result in production of superoxide
and H2O2 outside the cell.7-11 It is thought that the generation of reactive species in
chronically inflamed tissue contributes to the pathogenesis of several diseases, including
the formation of atherosclerotic plaques,12-14 neurodegenerative diseases,15-18 arthritis,19, 20
and certain cancers.21-24
The high reactivity of HOCl means that it only exists transiently in vivo. To
determine the extent of HOCl production we must use more stable markers, typically the
byproducts of HOCl reacting with the bases of DNA or the amino acids of proteins.
While HOCl reacts with DNA bases to form hydroxylated or chlorinated uracil and
cytosine,25-27 damaged DNA bases can be readily repaired. The reaction with the amine
groups of histidine or lysine side-chains to form chloramines is rapid,28, 29 but these
chloramines can react further and chlorinate other compounds.29-31 The chlorination of

88

tyrosine, however, forms stable and unique products 3-chlorotyrosine (3ClTyr) and 3,5dichlorotyrosine (Cl2Tyr).32-34 These two markers have been measured from in vivo
samples including in asthmatic sputum and in cultures in which staphylococcus aureus is
phagocytized by neutrophils.35, 36
The direct chlorination of tyrosine residues by HOCl or HOCl-induced
chloramines is slow.37 This contradicts studies that show greater yields of 3ClTyr and
Cl2Tyr at tyrosine residues that are near histidine or lysine residues within proteins,
particularly those that are in a KxxY sequence motif, where x is a residue that is
unreactive with HOCl.33, 38 The mechanism of 3ClTyr formation proposed by others38, 39
and determined in our previous studies37, 40 is by the intramolecular reaction between a
lysine or histidine chloramine and a nearby tyrosine. While the effect of the spacing
between lysine and tyrosine residues on the yield of 3ClTyr has been explored
previously, there have been no studies examining how this changes the rate of
chlorination and comparing this rate to competing reactions with HOCl.
In this study, we synthesized several peptides containing histidine or lysine with a
varying number of residues between them and a 3-nitrotyrosine (NO2Tyr) residue.
NO2Tyr was chosen because it has a slower rate of reaction with HOCl or chloramines
than unmodified tyrosine yet undergoes the same mechanism of chlorination, making the
formation of chlorinated product easier to follow.40 These peptides were reacted with
HOCl and the rate of chlorination were measured to determine the effect the primary
structure had on tyrosine chlorination. Additionally, a cyclic peptide with a beta-sheet
motif was designed and synthesized to position a lysine and tyrosine residue in
constrained positions close in space in hopes of increasing the rate of chlorination. This
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secondary structure of this peptide was characterized by circular dichroism (CD)
spectroscopy and the rate of chlorination by HOCl was determined. The kinetics of
chlorination of these peptides further support the role of chloramines in the formation of
3ClTyr and Cl2Tyr within peptides and should allow future researchers greater ability to
predict the likelihood of tyrosine chlorination and better determine the degree of MPO
activity in chronically inflamed tissue.

Experimental Procedures
Materials
N-Acetyl-L-tyrosine (AcTyr), N-α-acetyl-L-lysine (AcLys), and N-acetyl-Lhistidine (AcHis) were purchased from Novabiochem (San Diego, CA). FMOC-amide
resin was purchased from Applied Biosystems, Inc. (Foster City, CA). FMOC-OSu,
FMOC-Lys(Boc)-OH, FMOC-His(Trt)-OH, and all other FMOC amino acids were
purchased from Advanced ChemTech (Louisville, KY), with the exception of FMOCTyr(NO2)-OH which was synthesized as described below. All other laboratory chemicals
including 3-chloro-L-tyrosine, 3-nitro-L-tyrosine, L-methionine, sodium hypochlorite, Nacetylglycine, N-acetyl-L-alanine, and N-acetyl-L-glutamic acid were purchased from
Sigma-Aldrich (St. Louis, MO). Synthesis of N-FMOC-3-nitrotyrosine was performed as
described in Chapter 3.

Linear Peptide Synthesis and Purification
Linear peptides containing lysine residues in varying proximity to the NO2Tyr
residue were synthesized on an ABI model 433A peptide synthesizer using fast FMOC
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chemistry. Following synthesis, the N-terminus was acetylated using acetic anhydride.
The protecting groups and resin support were cleaved from the peptides using a mixture
of TFA/phenol/water/triisopropylsilane (88:5:5:2). The resin was removed by filtration,
the cleavage reaction was concentrated by rotary evaporation, and then the peptide was
precipitated by adding cold diethyl ether to the cleavage mixture. The ether was removed
following centrifugation to pellet the precipitated peptide. After washing the crude
peptide with cold diethyl ether three times, the peptides were purified by reverse phase
HPLC using a C18 column (Varian Dynamax, 250 mm x 21.4 mm, 300 Å, 5 µM) with a
gradient of 20 - 60% mobile phase B (acetonitrile with 0.085% TFA) where mobile phase
A contained aqueous 0.1% TFA. The sequence of the purified peptides was confirmed by
MS/MS using a ThermoFinnigan LCQ Deca XP mass spectrometer, and a purity of >
95% was verified by analytical HPLC.

Synthesis of DPhe-chlorotrityl Resin
1 g of 2-chlorotrityl chloride resin was washed in dichloromethane (DCM) and
the resin was filtered. 2 mmol of FMOC-DPhe-OH and 5 mmol of N,Ndiisopropylethylamine (DIPEA) were dissolved in DCM and added to the resin. The resin
was washed twice with dimethylformamide (DMF) and a mixture of
DCM/methanol/DIPEA (80:15:5) was added to the resin for 10 min twice. The resin was
then washed with DMF three times then suspended in 25% piperidine in DMF while
being shaken for twenty minutes. The resin was washed again in DMF six times,
isopropanol three times, and hexane four times. The final product was dried by suction
and stored at 4 °C until use for peptide synthesis.
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Cyclic Peptide Synthesis and Purification
The cyclic, 10-residue peptide cyclo-P(OH)TKLDFP(OH)TYLDF (Figure 1) was
based on gramicidin S, another cyclic peptide that mimics a beta-pleated sheet motif.41
The linear, protected peptide was synthesized on DPhe-chlorotrityl resin using
fast FMOC chemistry and an ABI peptide synthesizer as described above. Beginning
with a DPhe-chlorotrityl resin has been shown to result in the highest yield of the final
cyclized product.44 The chlorotrityl resin was selectively removed while keeping the sidechain protecting groups intact by suspending the resin in 2,2,2-trifluoroethanol and DCM
(2:8) for 45 minutes at room temperature and filtering off the resin. The filtrate was
concentrated by rotary evaporation and the peptide was precipitated by the addition of
hexane and ether. The peptide was then centrifugated and the pellet was washed twice
with ether, leaving a linear, side-chain protected peptide, NH2P(OH)TKLDFP(OH)TYLDF-OH.
Approximately 100 mg of the crude, protected, linear peptide was diluted heavily
in 200 mL of DCM in order to favor intramolecular cyclization over intermolecular
polymerization.44 Cyclization was initiated by the addition of HBTU, HoBt hydrate, and
DIPEA to a final concentration of 1 mM, 1 mM, and 2 mM respectively. The reaction
was conducted at room temperature overnight and concentrated by rotary evaporation.
Following cyclization, the side-chain protecting groups were cleaved by reacting with
TFA/phenol/water/triisopropylsilane (88:5:5:2) for two hours followed by washing with
diethyl ether. The crude, cyclic peptide was purified by HPLC and the sequence was
confirmed by MS/MS as described above. Fragmentation of the cyclic peptide by MS/MS
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Figure 1: Structure of cyclo-P(OH)TKLDFP(OH)TYLDF. This structure was based on
the cyclic decapeptide gramicidin S, which is a known beta-sheet analogue. DPhe-Pro
bonds induce II’ beta-turns and hydrogen bonds between anti-parallel strands further
stabilize the structure.42, 43 When this ten-residue peptide is cyclized, the side-chains of
lysine (red) and tyrosine (blue) are on the same surface of the ring structure.
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showed unique peptides confirming the cyclization occurred between the N-terminal
hydroxyproline and C-terminal phenylalanine (Appendix F)

Methods
The purchased sodium hypochlorite stock was stored at 4 °C. The pKa of HOCl is
7.5 resulting in almost equal concentrations of hypochlorous acid and its conjugate base,
hypochlorite, at physiological pH. The term “hypochlorous acid” is thus used to refer to
both the acid and its conjugate base. The concentration of the sodium hypochlorite stock
was determined daily using the absorbance at 290 nm (ε290 nm = 350 M-1cm-1) for a fresh
dilution of the stock into 0.1 M NaOH.45 Dilutions of HOCl stock were then made into 20
mM phosphate buffer at pH 7.4. The stock concentrations of peptides containing Tyr or
NO2Tyr were determined following dilution into 0.1 M HCl and using UV/vis
spectroscopy with molar absorptivity values of ε275 nm = 1368 M-1cm-1 and ε360 nm = 2790
M-1cm-1, respectively.46, 47

Reaction of Peptides with HOCl
200 µL of HOCl was reacted with an equal volume of excess peptide at
concentrations of 10 - 120 µM HOCl and 20 – 240 µM peptide in 10 mM phosphate
buffer at pH 7.4. Reactants were rapidly mixed in 1.5 mL glass vials in an aluminum
block at 37 ºC and the reaction was stopped by the addition of 200 µL of 10-fold excess
cysteine at time points between 5 s and 12 hr.
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HPLC Quantitation of Reaction Products
The concentration of products and reactants in kinetic samples were measured
using a ThermoFinnigan (Waltham, MA) Surveyor HPLC system with a MS Pump,
Autosampler, and PDA detector (200-600 nm). The solvent gradients used for peptides
containing tyrosine or NO2Tyr are described in Chapters 2 and 3, respectively. Kinetic
samples were run directly on the HPLC without further dilution. The Qual browser
module of Xcalibur, ver. 1.3 (Thermo-Finnigan, Ontario, Canada) was used to analyze
the HPLC chromatogram. Standard curves using N-acetylated analogues of tyrosine,
3ClTyr, and Cl2Tyr or NO2Tyr and N-acetyl-3-chloro-5-nitrotyrosine (ClNO2Tyr) were
obtained periodically to ensure that measured concentrations were accurate. ClNO2Tyr
was synthesized as previously described.40

Analysis of Kinetics Data and Determination of Rate Constants
Microsoft Excel was used to analyze all kinetic data using a model comparison
method.48 The kinetic scheme and the differential equations used to model the rate
constant are described in Figure 2. A time interval of 0.1 s was used to numerically
model the differential equations. The sum of the squared differences (SSD) was
calculated between the experimental and modeled concentrations for time points in a
kinetics experiment. The Solver tool in Excel was used to determine the optimized
second order rate constants that minimized the SSD giving SSDopt. The error in each rate
constant was estimated by determining the rate constant that gave SSD =
SSDopt*(F(P/(N-P))+1) where F is the critical value of the F distribution, P is the number
of model parameters, and N is the number of data points. We chose a value of F
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A. Scheme of Intramolecular Tyr or NO2Tyr Chlorination

B. Differential Equations
𝑑[Chloramine/Tyr]
= −k1 ∗ [Chloramine/Tyr Peptide]
𝑑𝑡
𝑑[Amine/3ClTyr]
= +k1 ∗ [Chloramine/Tyr Peptide]
𝑑𝑡
Figure 2: Kinetic Scheme of Intramolecular Tyrosine Chlorination. (A) The
chlorination of tyrosine or NO2Tyr by HOCl in a lysine-containing peptide is through a
chloramine intermediate. Lysine’s side-chain amine is chlorinated quickly relative to the
rate of tyrosine chlorination, such that any HOCl rapidly chlorinates the amine to form a
chloramine. Therefore, the amount of Chloramine / Tyr peptide is equivalent to the amount
of HOCl added, provided the peptide is available in excess. (B) Differential equations were
used to solve for the intramolecular rate constant, k1, as described in the Methods section.
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corresponding to the 95% confidence level. The rate constant values are reported as
middle value ± ½*range; the middle value was calculated from the high and low SSD
values that defined the range of certainty (95% confidence level) and were within 1% of
the optimized value in all cases.

Characterization of Secondary Structure by Circular Dichroism
CD samples were prepared by diluting concentrated peptide stock of a known
concentration into 200 mM phosphate buffer, pH 7.4, to obtain a final concentration of
200 µM peptide in a cell with a path length of 0.1 cm. The concentration of the stock
solutions was determined by UV/vis spectroscopy using the molar absorptivity of
tyrosine (ε275 nm = 1368 M-1cm-1).46 CD spectra were recorded using a JASCO model J720
spectropolarimeter with a nitrogen flow rate of 5 L/min. Typical spectral accumulation
parameters were a time constant of 1 sec and a scan rate of 100 nm/min with a 0.5 nm
step resolution over the range of 195-350 nm with 12 scans averaged for each spectrum.
The accumulated average spectra were trimmed at a dynode voltage of 700 prior to
baseline subtraction and smoothing using the reverse Fourier transform procedure in the
KASCO software. CD spectral values for peptides were expressed in units of residue
molar ellipticity (deg • cm2 / residue dmol). The temperature of the CD cell was
equilibrated at each temperature for 15 min prior to acquisition of the spectra. The initial
temperature was 5 °C and was increased in 10 °C increments to 65 °C.
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Results
Spacing of Lysine and Tyrosine Residues Alters Rate of Chlorination
To examine the effect that the spacing between the chloramine and the NO2Tyr
residue had on the rate of chlorination, we synthesized peptides with 0-3 residues
between the lysine and NO2Tyr residues. These peptides were characterized and shown to
have very similar pKa values around 6.9 and CD spectra analysis showed all peptides
were unstructured (Appendix G). Each peptide was reacted with HOCl at 37 °C, in 10
mM phosphate buffer at pH 7.4 to calculate the initial rate of ClNO2Tyr production. The
reactions were stopped by introducing excess cysteine, which rapidly reacts with lysine
chloramine at a rate of about 108 M-1s-1,28, 29 and the resulting peptides were quantitated
by HPLC. The initial reaction kinetics were all independent of peptide concentration and
first order with respect to HOCl concentration, as seen previously in linear peptides
containing histidine chloramine and NO2Tyr.40 The rate constants and pKa values for the
four peptides containing NO2Tyr used in this study are summarized in Table 1.

CD Spectra of Cyclic Peptide Indicates Gramicidin S Homology
The CD spectra of cyclo-P(OH)TKLDFP(OH)TYLDF in aqueous phosphate buffer
at pH 7.4 was determined at temperature ranging from 5 °C to 65 °C (Figure 3). The
negative minima around 200 and 220 nm are similar to those exhibited by cyclic
gramicidin S analogues, as previously reported.44, 49, 50 According to the work of
Jelokhani-Niaraki et al., gramicidin S analogues with distorted sheet and turn structures
exhibit more negative ellipticities around 200 nm than 220 nm and vary more with
temperatures compared to gramicidin S analogues with more stable antiparallel beta-
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Table 1. Rate Constants for Chlorination of NO2Tyr by Lysine Chloramine within a
Peptidea

a

Peptide Sequence

Residues between
Lys and NO2Tyr

Rate Constant (s-1)

pKa

Ac-GNK-Y(NO2)-AE-NH2

0

6.18 ± 0.18 x 10-5

6.8 ± 0.1

Ac-GKN-Y(NO2)-AE-NH2

1

7.05 ± 0.22 x 10-5

6.8 ± 0.1

Ac-KGN-Y(NO2)-AE-NH2

2

2.54 ± 0.03 x 10-5

6.9 ± 0.1

Ac-KGNA-Y(NO2)-E-NH2

3

1.96 ± 0.09 x 10-5

6.9 ± 0.1

Reactions were performed at 37 ºC, pH 7.4 in 10 mM phosphate buffer.
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Figure 3: CD Spectra of cyclo-P(OH)TKLDFP(OH)TYLDF. The secondary structure of
the gramicidin-S analogue, cyclo-P(OH)TKLDFP(OH)TYLDF, was analyzed by CD
spectroscopy at a concentration of 200 µM in 200 mM phosphate buffer at pH 7.4. The
arrow indicates the change in the CD spectra as the temperature of the sample was
increased from 5 °C (bold) to 15, 25, 37, 45, and 65 °C, consecutively. Cooling the
temperature back to 5 °C indicated no significant change from the initial measurement
(data not shown). The large negative ellipticities around 200 and 220 are similar to those
exhibited by cyclic gramicidin S analogues as previously reported.49
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sheets which have double minima at 205 and 220 nm with comparable ellipticities and have
minimal changes in secondary structure with temperature changes.49 Our gramicidin S
analogue, cyclo-P(OH)TKLDFP(OH)TYLDF, shows characteristics more in common with
the distorted gramicidin S analogues, though the CD spectra of the peptide at 65 °C has
minima at 205 and 220 nm that may be consistent with the antiparallel beta-sheets in
gramicidin S.

Rate of Tyrosine Chlorination by Lysine Chloramine Increased in Cyclic Peptide
Approximately 75 µM of the cyclic peptide cyclo-P(OH)TKLDFP(OH)TYLDF
was reacted with 50 µM HOCl in 10 mM phosphate buffer at pH 7.4 at 37 °C. The
reaction was stopped by the addition of excess cysteine at varying time points and the
tyrosine- and 3ClTyr-containing peptides were quantitated by HPLC (Figure 4A). The
product peak was confirmed to contain 3ClTyr by its UV-spectra and its mass by LC-MS
(data not shown). The loss of tyrosine-containing peptide and growth of 3ClTyrcontaining peptide were modelled according to our kinetic scheme in Figure 2 and the
rate constant was determined to be 1.02 x 10-3 s-1 (Figure 4B).

Discussion
The biomarker 3ClTyr is formed when HOCl, the unique product of MPO,
chlorinates the phenol ring of tyrosine. HOCl can also chlorinate amino groups on the
side-chains of lysine or histidine. While it has been postulated previously that the
chlorination of tyrosine in vivo is through chloramine intermediates, the rate of
chlorination of free tyrosine by free chloramine is slow.29 Studies have since shown that,
in proteins, 3ClTyr formation is favored in tyrosine residues that are located near a lysine
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Figure 4: Kinetics of cyclo-P(OH)TKLDFP(OH)TYLDF Chlorination by HOCl. 75
µM of the peptide cyclo-P(OH)TKLDFP(OH)TYLDF was reacted with 50 µM HOCl at in
10 mM phosphate buffer at pH 7.4 at a temperature of 37 °C and the reaction was stopped
by the addition of excess cysteine at set time points. (A) HPLC was used to monitor the
decrease of cyclo-P(OH)TKLDFP(OH)TYLDF at and the increase of the chlorinated
product cyclo-P(OH)TKLDFP(OH)TY(Cl)LDF. This shows the amount of product
formation after 5 minutes. (B) The concentration of each species was quantitated from the
UV-HPLC and were modeled to determine the rate constant of chlorination. The solid lines
represent the modeled reaction progress with an optimized rate constant. The
intramolecular rate of chlorination in this peptide was determined to be 1.02 x 10-3 s-1.
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or histidine residue.33, 39 The proposed reason for these increased yields of chlorination is
that the restriction in freedom between lysine and tyrosine allows the likelihood of their
collision to increase and favoring their reaction together (Figure 2).37, 40 For example,
Bergt et al. discovered that tyrosine residues in alpha-helices are preferentially
chlorinated when in the sequence motif KxxY or KxxxY, where x is a residue that is
unreactive with HOCl.38 These studies only looked at the yields of 3ClTyr in simple
systems. In order to be able to predict how likely 3ClTyr formation would be in a more
complicated system, such as in the human cell where antioxidants are present, we need to
determine how the rate of chlorination can change with structure.
To investigate how spacing between lysine and tyrosine can affect the rate of
chlorination, we synthesized peptides containing a varying amount of residues between
NO2Tyr and lysine. Chlorination of NO2Tyr by HOCl or choramines has been previously
determined to follow the same mechanism as chlorination of tyrosine and is
approximately three-fold slower,40 which allows us to more easily follow the growth of
chlorinated product over time. The rate constants of these peptides were determined and
are shown in Table 1. We see that the sequence motif that had the fastest rate of
chlorination was KxY(NO2), followed by KY(NO2), KxxY(NO2), and KxxxY(NO2),
respectively. The fastest rate constant was only approximately 3.5-fold faster than the
slowest in these motifs. The effect of sequence on the intramolecular kinetics of
chlorination is independent of a defined peptide secondary structure since all peptides
examined in this report have negligible helical structure as shown by circular dichroism
spectroscopy (Appendix G). If we were to extrapolate from this model to the
chlorination of tyrosine and formation of 3ClTyr, the fastest rate of chlorination in the
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KxY motif would be approximately 2 x 10-4 s-1. Based on previous trends,37, 40 this may
be enhanced 1000-fold by replacing lysine with histidine, up to a rate of about 0.2 s-1 in a
HxY motif.
Our determination that the KxY(NO2) sequence motif has the fastest rate of
chlorination seemingly contradicts the previous study that identifies KxxY and KxxxY as
having the greatest yields of 3ClTyr.38 We believe that this discrepancy lies in the
secondary structure of the peptides being studied. Bergt et al. were studying peptide
fragments from apolipoprotein A-I which are known to lie in regions with alpha-helix
characteristics.51 In an alpha-helical structure, residues that are spaced with two or three
residues between them appear on the same face of the helix.52, 53 Our own peptides in this
study were completely unstructured and therefore present only the effect of the amino
acid sequence on 3ClTyr formation. This suggests that secondary structure may play a
significant role in the rate of tyrosine chlorination and warrants further investigation.
To investigate the role of secondary structure on tyrosine chlorination by HOClinduced lysine chloramine, we attempted to synthesize a peptide that restricted lysine and
tyrosine closely in space to increase the reaction kinetics. Our peptide, cycloP(OH)TKLDFP(OH)TYLDF (Figure 1), was based on the structure of the cyclic
decapeptide gramicidin S, which is known to have a beta-pleated sheet motif with several
hydrogen bonds between the parallel strands.41, 42, 54 To verify that our peptide was
properly cyclized and had the appropriate beta-sheet characteristics, we characterized the
peptide by LC-MS/MS (Appendix F) and circular dichroism (Figure 3). These studies
indicated that our peptide was cyclized correctly and had strong homology to gramicidin
S. These characteristics theoretically favor the intramolecular transfer of chlorine from
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the lysine chloramine. The kinetic study was performed and the rate constant was
determined to be 1.02 x 10-3 s-1 (Figure 4). This is about 5-fold faster than the proposed
rate of chlorination in a KxY motif we extrapolated above.
In the human cell, there are a plethora of available reactants for HOCl that
compete with tyrosine. Reduction of HOCl by antioxidants such as glutathione or the
sulfur-containing amino acids methionine and glutathione are rapid with rate constants
ranging from 105 to 108 M-1s-1.28, 31 These are significantly faster than the rate of
chlorination of tyrosine by HOCl at 71 M-1s-1.37 However, the reaction of HOCl with
histidine or lysine to form chloramines at 104 to 105 M-1s-1,27, 28 is better able to compete
with the antioxidants. Furthermore, the accelerated chlorination of tyrosine residues
nearby histidine or lysine discovered in this study would further increase the incidence of
3ClTyr formation even in the presence of antioxidants. This evidence suggests that
chloramines play a significant role in formation of the biomarker 3ClTyr in vivo and that
the majority of 3ClTyr formed will be protein-bound and will not exist as free amino
acids.
Additionally, the regioselectivity of tyrosine chlorination seen in this study has
implications in the formation of the 3ClTyr byproduct Cl2Tyr. Several studies have
shown that concentrations of 3ClTyr in polypeptides will plateau then decrease as
increasing amount of HOCl are added.33, 55, 56 The loss of 3ClTyr is accounted for if
Cl2Tyr is concurrently measured.37 Because the chlorination of 3ClTyr by HOCl or
chloramines undergoes the same mechanism of chlorination as tyrosine, the same
regioselectivity applies. In other words, peptide primary or secondary structures that
position chloramine and tyrosine close together and favor 3ClTyr formation will also
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favor Cl2Tyr formation. It is our recommendation that any study that measures 3ClTyr to
correlate it to MPO activity must also measure Cl2Tyr in order to avoid underestimating
the degree of inflammation.
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CHAPTER FIVE
DISCUSSION
Loss of 3ClTyr and NO2Tyr by HOCl
3-Chlorotyrosine (3ClTyr) and 3-nitrotyrosine (NO2Tyr) are useful as markers of
myeloperoxidase (MPO) activity in inflammatory tissue because they are stable and
readily measurable. Two studies called into question their stability as concentrations of
these markers decrease upon exposure to hypochlorous acid (HOCl), the unique product
of MPO.1, 2 If the rate of decrease is sufficiently fast, it would implicate that any previous
study measuring these markers potentially underestimated the activity of MPO. In our
study we identify the products of 3ClTyr or NO2Tyr reacting with HOCl and determine
the kinetics of chlorination, summarized in Figure 1.
The product of HOCl reacting with 3ClTyr is 3,5-dichlorotyrosine (Cl2Tyr), as
reported by several previous studies.3-6 The rate constant of chlorination of 3ClTyr was
determined to be 238 M-1s-1, approximately 3-fold faster than the rate of chlorination of
tyrosine at 71 M-1s-1. Although the rate constant is greater, there are several orders of
magnitude more tyrosine than 3ClTyr in a cell; studies in vivo observe 0-1000 µmol of
3ClTyr per mol of Tyr.7-11 This would suggest that HOCl reacting with 3ClTyr would be
insignificant. However, in the few studies that measured Cl2Tyr in vivo, the amount
observed is similar to the amount of 3ClTyr.12-14
Pattison et al., who had previously overestimated the rate of tyrosine chlorination
by HOCl,15 have since accepted our determined rate constants.16 They, and others, have
since used these values to argue that previous studies only measuring 3ClTyr without
Cl2Tyr may be underestimating the degree of MPO activity.16-18 We agree with this
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Figure 1: Products of 3ClTyr and NO2Tyr Reacting with HOCl or Chloramines. Nacetylated analogues of tyrosine were used in these studies to prevent oxidation of the
amino-group of tyrosine. Ac3ClTyr, N-acetyl-3-chlorotyrosine; AcCl2Tyr, N-acetyldichlorotyrosine; AcClNO2Tyr, N-acetyl-3-chloro-5-nitrotyrosine; AcNO2Tyr, N-acetyl3-nitrotyrosine; AcTyr, N-acetyltyrosine; HOCl, hypochlorous acid; NO2•, nitrogen
dioxide; NO2Cl, nitryl chloride.
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assessment that MPO activity has likely been underestimated. Because of the increased
rate of 3ClTyr chlorination by HOCl and the high yields of Cl2Tyr observed in vivo, we
recommend that any future studies that measure 3ClTyr should also measure Cl2Tyr
simultaneously.
The product of HOCl reacting with NO2Tyr is 3-chloro-5-nitrotyrosine
(ClNO2Tyr). The rate of NO2Tyr chlorination by HOCl was determined to be 24.5 M-1s-1,
three-fold slower than the chlorination of tyrosine by HOCl. These slower kinetics,
combined with the fact that regioselectivity of tyrosine chlorination differs from that of
tyrosine nitration, suggest the ClNO2Tyr formation is likely to be insignificant in vivo.6, 19
Furthermore, NO2Tyr formation is not specific to MPO activity; tyrosine can be nitrated
by peroxynitrite, which is formed with superoxide reacts with nitric oxide independent of
MPO.20 In fact, one study has determined that tyrosine nitration is predominantly
mediated in peroxynitrite-dependent pathways in human cells.21 No studies to date have
tried to measure ClNO2Tyr in vivo and, based on these results, we do not recommend it as
a future study direction.

Chlorination of Tyrosine by Chloramines
Chlorination of tyrosine by HOCl (71 M-1s-1) is much slower than the reduction of
HOCl by antioxidants such as glutathione (~108 M-1s-1) or sulfur-containing amino acids
like cysteine and methionine (~107 M-1s-1).15 As such, it has been argued that any 3ClTyr
measured in vivo only occurs after the oxidation of all available antioxidants.22 One
proposed alternative explanation is that HOCl-induced chloramines, such as histidine or
lysine chloramine, are intermediates in the chlorination of tyrosine. This is evidenced by

114

the preferential chlorination of tyrosine on proteins that are nearby histidine or lysine
residues.5, 6, 23
The rates of tyrosine chlorination by histidine and lysine chloramines as free
amino acids (3 M-1s-1 and 0.004 M-1s-1, respectively) determined in this study are
significantly slower than direct chlorination of tyrosine by HOCl. This alone cannot
explain the preferential chlorination of tyrosine near these residues in peptide. However,
when tyrosine and lysine are constrained in close proximity within a peptide, the rate of
chlorination increases significantly. Our study of chlorination of the peptide AcKGNYAE-NH2 by HOCl showed an initial velocity (V0) 600-fold greater than an
analogous amino acid mixture (see Chapter 2, Figure 7). This is likely due to the
reduced degrees of freedom of the tyrosine and lysine side-chains when they are confined
to the same peptide. The intermolecular kinetics of tyrosine analogue chlorination by
HOCl or chloramines are summarized in Table 1.
Additionally, lysine chloramine may protect chlorination potential from reduction
by antioxidants such as glutathione. The fast reaction of HOCl to form lysine chloramine
(~105 M-1s-1) better competes with the antioxidant glutathione (~108 M-1s-1) than the
direct chlorination of tyrosine analogues (~102 M-1s-1). The lysine chloramine would then
be able to undergo intramolecular chlorination of tyrosine prior to reduction by
glutathione, provided the intramolecular kinetics are sufficiently fast.24, 25 Figure 2
provides a schematic highlighting the relevant kinetics.
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Table 1: Summary of Tyrosine Analogue Chlorination as Free Amino Acids. All
reactions were performed at 37 °C in 100 mM phosphate buffer at pH 7.4.

a

Chlorinating
Species

AcTyr
(M-1s-1)

Ac3ClTyr
(M-1s-1)

AcCl2Tyr
(M-1s-1)

AcNO2Tyr
(M-1s-1)

HOCl

71 ± 8

238 ± 27

32 ± 6

24.5 ± 1.2

HisCl

3.0 ± 0.3

10.4 ± 1.0

1.7 ± 0.2

1.1 ± 0.2

LysCl

0.004 ± 0.003

0.008 ± 0.002

0.003 ± 0.002

NDa

No significant amount of product was detected after two hours of reaction
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Figure 2: Summary of Reactions by HOCl that Compete with 3ClTyr Formation. All
rate constants are for individual amino acid analogues. The rate constants for HOCl or
chloramines reacting with sulfur containing amino acids or glutathione and primary amines
reacting with HOCl are published elsewhere.15, 26 The remaining rate constants are from
Table 1.
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Effect of Peptide Primary Structure on Tyrosine Chlorination by HOCl
It has been determined previously that tyrosine is preferentially chlorinated by
HOCl if it is on a peptide and near a lysine or histidine residue.5, 6 Bergt et al. in
particular created several peptide fragments in an alpha-helical arrangement that
separated tyrosine from lysine by varying residues.6 They saw that peptides with a KxxY
or KxxxY motif (where x is a residue unreactive with HOCl) showed the greatest yields
of 3ClTyr, though the kinetics were not determined. In addition, their observation that
tyrosine at residue 192 on apolipoprotein A-I was preferentially chlorinated was
attributed to a KxxY motif, which ignored the fact that histidine on residue 193 also
contributes to 3ClTyr formation.23
Our study set out to determine what effect changing the spacing between tyrosine
and lysine had on the rate of chlorination in a simple, unstructured peptide. Using
peptides with a varying number of residues between lysine and NO2Y (NO2Y rather than
tyrosine was used because its slower rate of chlorination and unique UV-spectra assisted
with analysis), we determined the rate constants of tyrosine chlorination. The effect of
lysine positioning on the rate of NO2Y chlorination was such that KxY > KY > KxxY >
KxxxY. The rates of the four peptides studied varied minimally, with the fastest at 7 x 105 -1

s being only 3.5-fold faster than the slowest. Additionally, replacing a lysine residue

with histidine accelerated the chlorination kinetics 1000-fold more, suggesting that
histidine chloramine is the more likely cause of 3ClTyr formation at residue 192 of
apolipoprotein A-I. Table 2 summarizes the kinetics of tyrosine chlorination in the
peptides we synthesized in these studies.
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Table 2: Summary of Tyrosine Analogue Chlorination in Peptides. All reactions were
performed at 37 °C in 10 mM phosphate buffer at pH 7.4.
Peptide Sequence

Rate Constant (s-1)

Ac-HGNY(NO2)AE-NH2
Ac-GNKY(NO2)AE-NH2
Ac-GKNY(NO2)AE-NH2
Ac-KGNY(NO2)AE-NH2
Ac-KGNAY(NO2)E-NH2

2.60 ± 0.53 x 10-2
6.18 ± 0.18 x 10-5
7.05 ± 0.22 x 10-5
2.54 ± 0.03 x 10-5
1.96 ± 0.09 x 10-5

Ac-KGNYAE-NH2
cyclo-P(OH)TKLDFP(OH)TYLDF-

2.38 ± 0.07 x 10-4
1.02 x 10-3
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Our results demonstrating that the KxY motif is faster than the KxxY or KxxxY
motifs may appear to contradict what was reported by Bergt et al.6 However, their study
utilized peptide fragments that were alpha-helical analogues and had even greater alphahelical characteristic while lipid-associated, increasing ClTyr yields. In an alpha helix,
the lysine residues would appear on the same face as the tyrosine residues when spaced
three or four residues away. Additionally, the structure of the apolipoprotein A-I
fragment they synthesized had its crystal structure analyzed previously, demonstrating
that the tyrosine and lysine alpha-carbons are only 4.5 Å from each other.27, 28 These
results suggest that the secondary structure of a protein may be more important to the
chloramine-induced formation of 3ClTyr than the primary structure, and warranted
further study.

Effect of Peptide Secondary Structure on Tyrosine Chlorination by HOCl
Our final study was to determine how the secondary structure could affect the rate
of tyrosine chlorination by HOCl-induced chloramines. Ideally, the structure would place
a chloramine near the tyrosine phenol ring and constrict the degrees of freedom to further
facilitate chlorination. We synthesized the peptide cyclo-P(OH)TKLDFP(OH)TYLDF
which is based on gramicidin S, a short peptide known to have a beta-pleated sheet
motif.29 Beta-turns in this peptide are induced by Pro-DPhe bonds, with the hydrogen
bonds between the anti-parallel strands further stabilizing the structure.30, 31 We modified
the structure to include lysine and tyrosine on opposite strands, as well as using hydroxyproline and threonine to add hydrophilic characteristics to the peptide, allowing us to
perform kinetics under the same conditions as our previous studies. CD spectroscopy of
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this peptide indicated that it was homologous to other gramicidin S analogues and has
slightly disorganized beta-sheet structure and beta turns as opposed to the anti-parallel
beta-sheets seen in native gramicidin S (see Chapter 4, Figure 3).
We determined the rate of tyrosine chlorination by lysine chloramine in cycloP(OH)TKLDFP(OH)TYLDF to be 1 x 10-3 s-1. This is approximately 5-fold faster than the
rate of tyrosine chlorination by lysine chloramine in the simple unstructured peptide AcKGNYAE-NH2. While we expected a more significant increase in the rate of
chlorination, this does support the hypothesis that secondary structure can facilitate an
increased rate of chlorination of tyrosine by lysine chloramine. Additionally, if we
extrapolate the difference between AcTyr chlorination by lysine chloramine versus
histidine chloramine, we expect the intramolecular rate of tyrosine chlorination by
histidine in a similar cyclic peptide to be 1000-fold greater at 1 s-1. Our kinetic studies
support the claims of other researchers that propose that formation of 3ClTyr in vivo is
predominantly facilitated by intramolecular chlorination by chloramines in a peptide.5, 6,
32

Furthermore, the regioselectivity of specific tyrosine residues in a protein would favor

further chlorination of the same tyrosine residue, suggesting that measurement of proteinbound Cl2Tyr may be a relevant marker of inflammation.

Overall Trends in the Kinetics of Chlorination of Tyrosine Analogues
Table 1 provides a summary of the chlorination of tyrosine analogues from
Chapters 2 and 3. The rate of direct chlorination of tyrosine is approximately 22-fold
greater than by histidine chloramine and 21,000-fold greater than by lysine chloramine,
averaged across all tyrosine analogues. Chlorination of AcTyr across all chlorinating
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species is approximately 3.4-fold slower than Ac3ClTyr chlorination, 2-fold faster than
AcCl2Tyr oxidation, and 2.8-fold faster than AcNO2Tyr chlorination.
In the context of peptides, this trend between the rate of chlorination by histidine
chloramine and lysine chloramine holds true. Comparing the rate of chlorination of the
peptides Ac-HGNY(NO2)AE-NH2 and Ac-KGNY(NO2)AE-NH2 (Table 2), there is an
approximately 1000-fold difference between the rate of chlorination. This is similar to the
difference between the rates of chlorination of AcTyr, Ac3ClTyr, and AcCl2Tyr by
histidine and lysine chloramines.
This same trend does not hold true for the difference between tyrosine and
NO2Tyr chlorination in lysine-containing peptides. Comparing the rate of chlorination in
Ac-KGNYAE-NH2 and Ac-KGNY(NO2)AE-NH2 (Table 2) demonstrates that tyrosine is
chlorinated about 9-fold faster than NO2Tyr. However, as free amino acids, AcTyr is
chlorinated about 3-fold faster. This discrepancy has several potential explanations. First,
our peptide reactions used a lower concentration of phosphate buffer than our amino acid
reactions (10 mM and 100 mM, respectively). If the pH were slightly closer to 8.5, this
would cause an increase in the rate of tyrosine chlorination and a decrease in the
chlorination of NO2Tyr (see Chapter 2, Figure 6 and Appendix E). Second, the steric
effect of the nitro-group on NO2Tyr may affect the secondary structure of the linear
peptide in ways that unmodified tyrosine would not, such that lysine chloramine had
easier access to tyrosine to facilitate chlorination. Another possible explanation is
variance due to human error.
The third explanation, human error, is the most likely. It may be that we did not
perform the kinetic study of Ac-KGNYAE-NH2 carefully enough. It was the first peptide
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we studied and was before we learned that one must be rapidly mixing the reaction
vessels with stir bars to uniformly distribute HOCl and prevent HOCl from being present
in excess, both of which lead to HOCl chlorinating tyrosine in a bimolecular reaction.
Support of this occurring is in the presence of peptide containing Cl2Tyr (see Chapter 2,
Figure 7) which should be impossible if only an intramolecular reaction between lysine
chloramine and tyrosine occurred. Before any comparisons can be made in this regard,
the peptide Ac-KGNYAE-NH2 would need to be resynthesized and the kinetic study
repeated.

Future Directions
First, to prepare our latest study for publication, we intend to further characterize
the secondary structure of the cyclic peptide by measuring changes in chemical shift
deviation by NMR versus temperature.33 Further controls may also be added to the study,
such as determining kinetics of unstructured, linear analogues of our cyclic peptides. It
would also be of interest to determine whether a histidine analogue of our cyclic peptide
truly exhibits the 1000-fold increase in kinetics that we expect.
Our next goal would be to establish the link between HOCl concentration and the
amount of 3ClTyr and Cl2Tyr in human cells. Currently, there are no accurate estimates
of the amount of HOCl in inflamed tissue, though estimates have been made based on the
capability of neutrophils to generate HOCl over time.34-36 By exposing human cells to
HOCl and quantitating the amount of 3ClTyr and Cl2Tyr per mol of tyrosine using
previously established methods,37 we can begin to better correlate these markers to MPO
activity. Additionally, due to the rapid reduction of reactive species in the cytoplasm, it is
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thought that significant quantities of HOCl have difficulty making it to the nucleus.38 It
would be informative to measure 3ClTyr and Cl2Tyr quantities in histones of cells
exposed to HOCl and compare those to overall levels.
Lastly, we would want to take the methods we’ve developed in the previous
studies and measure the biomarkers 3ClTyr and Cl2Tyr in human samples. We have
already discussed with clinicians and other researchers the possibility of analyzing serum
samples of patients with sepsis or of hypoxic newborns to determine the level of MPO
activity through 3ClTyr and Cl2Tyr measurement. These can be compared to the current
clinical standards of inflammation such as the erythrocyte sedimentation rate and Creactive protein, both of which can have limited sensitivity at early stages of disease and
are nonspecific.39, 40 The measurement of 3ClTyr in conjunction with Cl2Tyr within
proteins of the serum may provide us a means of detecting inflammatory states earlier
than with the current clinical methods and perhaps provide insight into the mechanism of
pathogenesis. With LC-MS detection of chlorinated tyrosine becoming as sensitive as
GC-MS methods17, 41 and the growth of LC-MS/MS machines in hospitals capable of
these measurements,42 we believe that 3ClTyr and Cl2Tyr are promising markers of
inflammation for the clinical setting.
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Appendix A: Characterization of Ac-KGNYAE-NH2 Chlorination Products by
MALDI-TOF. MALDI-TOF was used to identify products of the reaction of AcKGNYAE-NH2 with HOCl. MALDI samples were prepared using the dried-droplet
method and 2,5-dihydroxybenzoic acid as the matrix. Samples were analyzed in negativeion reflectron mode by a Bruker Autoflex MALDI-TOF. The mass-to-charge ratio was
calibrated using a commercially-available peptide solution containing angiotensin I and II,
substance P, bombesin, clipped ACTH residues 1-17 and 18-39, and somatostatin. Due to
the weak signal of these standards in negative-ion mode, we also added the previously
characterized peptide Ac-KGNYAE-NH2 (MH- ion at 722.3468 m/z) to the standard mix
to achieve a more accurate standard curve. This shows the final products when 260 M
HOCl reacts with 125 M Ac-KGNYAE-NH2 at 37 °C for 1 hr. Peaks at 722.4, 756.8, and
790.9 m/z correspond to the MH- ions of the peptide containing tyrosine, 3-chlorotyrosine,
and 3,5-dichlorotyrosine, respectively. Peaks at 718.2, 752.7, and 786.9 m/z correspond to
the lysine nitrile form of the peptide with tyrosine, 3-chlorotyrosine, and 3,5dichlorotyrosine, respectively.
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Appendix B: GC-MS of Tyr, 3ClTyr, and Cl2Tyr. Approximately 100 µM of the peptide
Ac-KGNYAE-NH2 was reacted with 50 µM of HOCl at 37 °C and quenched with
methionine after one hour. An internal standard of isotope-labelled labeled [13C9]Tyr,
[13C6]3ClTyr, and [13C9]Cl2Tyr was added and the samples dried down. The peptide was
then hydrolyzed with HBr and phenol at 120 °C overnight before being dried down again.
The residues were then derivatized with propanol and heptafluorobutyric anhydride, as
previously described (Hazen et al., Free Radic Biol Med, 1997. 23(6): 909-916). The
resulting n-propyl, per-heptafluorobutyric derivatives of Tyr, 3ClTyr, and Cl2Tyr were
detected using an Agilent 6890N GC/5973N MSD instrument in negative chemical
ionization mode, as seen in the above figure. Quantitation of the tyrosine residues was
achieved by creating a standard curve based on the ratios of 417/426, 451/457, and 683/692
m/z for tyrosine, 3ClTyr, and Cl2Tyr, respectively. The amount of analyte detected using
this GC-MS method was not significantly different from the amount of analyte calculated
using our HPLC method described in Chapter 2.

131

Physiological
100

Percent Ionized

AcTyr
80

Ac3ClTyr

60

AcCl2Tyr

40

20

0
3

4

5

6

7

8

9

10

11

12

13

pH

Appendix C: Chlorination of Tyrosine Lowers the pKa Value of the Phenol Hydroxyl.
The curves plot the following function: percent ionized = (100 x 10(pH – pKa)) / (1 + 10(pH –
pKa)
), where the pKa value was fitted to the experimental data. The 100% ionized and 0%
ionized absorbance values were fitted to the experimental values at 242, 244, and 246 nm
for N-acetyltyrosine, N-acetyl-3-chlorotyrosine, and N-acetyl-3,5-dichlorotyrosine,
respectively. The calculated pKa values for N-acetyltyrosine, N-acetyl-3-chlorotyrosine,
and N-acetyl-3,5-dichlorotyrosine are 9.8, 8.5, and 6.7, respectively.
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Appendix D: Chlorination of AcNO2Tyr Lowers the pKa Value of the Phenol
Hydroxyl. Approximately 300 µM of AcNO2Tyr or AcClNO2Tyr were suspended in 100
mM phosphate buffer at the indicated pH values and the absorbance was measured by
UV/Vis spectroscopy. The absorbance at 430 nm for both compounds in 0.1 M NaOH was
assumed to represent 100% ionized while the absorbance value while in 0.1 M HCl was
assumed to represent 0% ionized. The curves plot the function, percent ionized =
(100·10(pH-pKa))/(1+10(pH-pKa)) where the pKa value was optimized to minimize differences
between the calculated and experimental values. The calculated pKa values for AcNO2Tyr
and AcClNO2Tyr are 7.1 ± 0.1 and 5.4 ± 0.1, respectively.
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Appendix E: pH-Dependence of the Apparent Rate Constant of AcNO2Tyr
Chlorination by HOCl. 750 μM AcNO2Tyr was reacted with 100 μM HOCl at the
specified pH for 5, 10, 15, 30, 45, and 60 s. The observed rate constant and error was
obtained by modeling the HPLC results as described in the Experimental Procedures. The
solid curve models the pH dependence of the apparent rate constant as kx[phenol][HOCl]
+ ky([phenol][-OCl] + [phenolate][HOCl]) + kz[phenolate][-OCl]. The pKa value for
AcNO2Tyr and HOCl used to calculate the relative concentrations of the acid and conjugate
base were 7.1 and 7.5, respectively. Due to the similarity in pKa values, it was necessary
to combine the rate constants of the phenol reacting with HOCl and the phenolate reacting
with -OCl. The rate constants are kx = 2.9 ± 1.0; ky = 35.6 ± 1.8; and kz = 1.6 ± 0.9 M-1s-1.
The preferred species for the chlorination reaction are either the phenol reacting with -OCl
or the phenolate reacting with HOCl.
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Peptide Sequence

Theoretical Mass (m/z)

Actual Mass (m/z)

LDFP(OH)TYLDF-P(OH)T

1112.6

1112.1

LDF-P(OH)TKLDFP(OH)T

1077.6

1077.3

LDFP(OH)TYLDF-P(OH)

1011.5

1011.4

D

FP(OH)TYLDF-P(OH)T

999.5

999.3

LDF-P(OH)TKLDFP(OH)

976.6

976.4

D

F-P(OH)TKLDFP(OH)T

964.5

964.1

P(OH)TYLDF-P(OH)T

852.4

852.2

F-P(OH)TKLDF
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750.2

YLDF-P(OH)
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536.9

D

Appendix F: Confirmation of Cyclic Structure of cyclo-P(OH)TKLDFP(OH)TYLDFby MS/MS. The purified, cyclic peptide, cyclo-P(OH)TKLDFP(OH)TYLDF-, was
analyzed using a ThermoFinnigan LCQ Deca XP mass spectrometer and confirmed to have
a mass of 1240.7 m/z. The original linear peptide sequence was NH2P(OH)TKLDFP(OH)TYLDF-CO2 and has a mass of 1258.7 m/z. To determine whether
cyclization occurred between the N-terminal hydroxyproline and the C-terminal
phenylalanine, we examined the daughter ions of the 1240.7 m/z mass and identified
peptide sequences that are only possible if the peptide is cyclized appropriately, shown
below. The results confirm the intended cyclic peptide was synthesized. Theoretical masses
were determined using the ProteinProspector tool from prospector.ucsf.edu.
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Appendix G: CD Spectra of Peptides Containing Lysine and NO2Y. Four indicated
peptides were diluted into 10 mM phosphate buffer at pH 7.4 with a final peptide
concentration ranging from 270 to 430 µM. The concentration was determined by
measuring the UV/Vis absorbance at 360 nm of similarly diluted samples in 0.1 M HCl.
The CD spectrum was measured on a JASCO model J720 spectropolarimeter at 37 ºC with
samples in a 1 mm-width cell. Data was measured between 200 and 270 nm in 0.5 nm
increments with 1 nm band width and 1 s dwell time. The CD was converted to ellipticity
by dividing by the path length, the concentration of the peptide, and the number of residues
in the peptide. The spectrum of all four peptides is typical of a disordered secondary
structure.
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